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LITERATURE REVIEW 
ANATOMY OF THE NEUROMYAL JUNCTION 
The skeletal neuromuscular junction (NMJ} is defined 
as an area where a motorneuron abuts a muscle cell. 
Amphibian and mammalian NMJs are the subjects of the most 
extensive electrophysiological studies. The reason for 
their popularity is the anatomy of the junction which lends 
itself to investigation by microelectrode techniques. The 
two main components of the structure are: a} the axon with 
its terminal and b} the muscle with its post-synaptic 
receptor area. Gross light microscopic examination reveals 
a large, white cable-like structure (nerve fibers) which 
seems to melt into muscle cells characterized by a light red 
color and striations. The contact area of an individual 
axon with a muscle cell will appear to be more dense than 
the surrounding areas. This dense area is the junctional 
region, a structure characteristic of chemical synapses. It 
reveals its complexity only under electronmicroscopic 
investigation. 
Upon such investigations, three distinct regions 
become apparent, the terminal, the cleft and the post-
synaptic membrane. Immediately, presynaptically, the nerve 
t e rm i n a 1 i s free of a my el i n s he et cove r i n g , c re at i n g a 
space of about 1.5 um where the nerve terminal is exposed to 
1 
2 
the immediate environment (Bowden and Duchen, 1976). The 
nerve terminal appears to be embedded in the sarcoplasm of 
the muscle. The interior of the nerve terminal is filled 
with dense vesicular structures with a diameter of about 50 
nm (deRobertis et al., 1954). In this case, these vesicles 
are thought to contain a neurotransmitter--acetylcholine. 
There are approximately 15,000 molecules of ACh per vesicle 
(Macintosh et al, 1976}. The pre-synaptic membrane is 
separated from the post-synaptic membrane by a space called 
the synaptic cleft. This is the area through which the 
neurotransmitter must travel to reach receptors located in 
the post-synaptic membrane. This post-synaptic membrane is 
specialized i.e., different from the extra-junctional 
membrane. Typically, the postsynaptic membrane is folded, 
forming clefts 0.5 to 0.7 JJm wide, thus increasing the 
surface area of the membrane. The extent of folding and the 
width of the cleft differs, depending on the species and the 
type of muscle investigated (Zacks, 1973). The crests of 
the junctional folds are covered with protein structures, 
identified as receptors by means of radiolabelled a-BTX. 
These receptors are most dense in the region of the folds, 
extending only a short distance into their necks (Fertuck et 
al., 1974}. The average density of the receptors at the 
mammalian endplate was calculated to be 3000/um. Each 
receptor-channel complex is composed of five peptide chains 
arranged in a rosette-type of configuration with a diameter 
3 
of about 85 A (Kistler et al., 1982). 
An acetylcholine receptor-channel complex is arranged 
with the recognition sites for the transmitter located only 
on the outer membrane surface. del Castillo et al. (1955) 
has shown that only externally applied ACh wi 11 produce a 
response. Experiments evaluating ACh receptor-kinetics 
conclude that two molecules of ACh are needed to open one 
channel (Dreyer et al., 1978). This work was supported by 
biochemical studies, showing that each ACh receptor-channel 
complex has two almost identical (a) sub-units (Karlin, 
1980). It is worth mentioning that despite the biochemictil 
studies performed predominantly on the electric organs of 
either the Torpedo Californica, Torpedo Marmorata or, to a 
lesser extent, on the fresh water electric eel, bo:h 
biochemically and physiologically, these receptors have 
proved to be related to mammalian, neuro-muscular receptors 
(Lindstrom et al., 1979; Lindstrom et al., 1979). 
Besides the ACh receptor-channel complexes protruding 
into the junctional cleft, there are other proteins which 
play an essential role in the physiology of the NMJ. These 
proteins are acetylcholinesterases (AChEs). The location of 
these enzymes is in association with both pre- and post-
junctional membranes with a greater concentration found at 
the latter site (Koelle et al., 1967). It appears that 
these enzymes are not integrated into the membranes, but 
rather coat them (Hall et al., 1971). Although not 
4 
completely understood, different species of these enzymes 
were identified (Hall, 1973). Using radio-labelled di-
isopropylfluorophosphonate (DFP), it has been estimated that 
the number of active hydrolytic sites per motor-endplate 
region is approximately the same as the number of ACh 
receptors (Barnard et al., 1971). Acetylcholinesterases are 
among the most efficient enzymes known, being capable of 
hydrolyzing a molecule of ACh in 80-100 microseconds (Wilson 
et al., 1961). 
5 
PHYSIOLOGY OF THE NEUROMUSCULAR JUNCTION 
Before a muscle becomes 
action potential 
excited, enabling it to 
down the axon. 
terminal, the 
contract, 
When the 
the 
action potential 
propagates 
reaches the 
electrical signal is transduced from an electrical to a 
chemical signal. As the chemical signal, a neurotransmitter 
(ACh) is released, ACh molecules travel from the release 
sites in the pre-synaptic membrane and through the synaptic 
cleft. Upon reaching their destination in the post-synaptic 
membrane, they bind with the receptors and activate the 
ionic channels. This leads to depolarization which in turn 
may or may not result in a muscle action potential. Muscle 
action potential generation depends upon the size of the 
depolarization relative to the threshold level. The 
depolarization level depends upon many processes: the amount 
of ACh released, the activity of AChEs, the integrity of the 
receptors and ionic channels, and the resting membrane 
potentials level as related to the membrane integrity. All 
of the above mentioned processes have been studied 
extensively and will be briefly reviewed here. More time 
will be devoted to those processes potentially involved in 
the effects of PLC on the NMJ (for a description of PLC 
activity, see the section on phospholipases). 
6 
ACh Synthesis 
Acetylcholine is synthesized from choline and acetyl-
coenzyme A in cholinergic axon terminals. This synthesis is 
catalyzed by the enzyme choline-o-acetyltransferase. This 
enzyme is believed to be synthesized in the cell body and 
then transported to the axon terminal (Ekstrom et al., 
1971). In the terminal, some of the enzyme is found to be 
associated with membranes; it is speculated that these may 
be vesicular membranes (Fonnum, 1973). 
Acetylcoenzyme A is synthesized in the mitochondria of 
the axon terminals under the direction of pyruvate 
dehydrogenase (Bremer, 1969). Since the inner mitochondrial 
membrane is impermeable to acetylcoenzyme A, 
are uncertain how acetylcoenzyme A enters 
(Tucek, 1967). 
investigators 
the cytosol 
In motor neurons, small amounts of choline appears to 
be present in the axon terminals (Potter, 1970). The bulk 
of choline needed for the synthesis of acetylcholine is 
derived from the external environment. It appears that the 
extra-cellular concentration of choline remains constant 
(Bligh, 1952). Evidence suggests that at least 50% of ACh 
released at the terminal and then hydrolyzed by AChE, is 
reabsorbed into the axon terminal (Potter, 1970). The 
extracellular choline concentration is maintained 
principally by diet. Some is synthesized in the liver 
7 
(Bremer, 1961); the newest information suggests that some of 
it may come from phospholipid metabolism (Blusztajn and 
Wurtman, 1983; also see below). 
Membrane phospholipids are a large, potential, choline 
depot. As it will be mentioned later, approximately 403 of 
the synaptic membrane phospholipids are in the form of 
phosphatidylcholine and 30% in the form of 
phosphatidylethanolamine (Barenholz, 1985). Both of these 
phospholipids are potential donors of choline. Choline may 
be generated from phosphatidylcholine hy means of 
phospholipase D activity, or by means of phospholipase C 
activity, followed by the dephosphorylation by alkaline 
phosphatase. On the other hand, phosphatidylmethanolamine 
must first be converted to phosphocholine by serial 
methylations. The enzymes involved are one and two 
phosphatidylethanolamine N-methyltransferases (for review, 
see Blusztajn and Wurtman, 1983}. 
Choline, being a charged molecule, is not ver}t lipid 
soluble. Thus, in order for it to re-enter the pre-synaptic 
cytosol, a special mechanism of transport must he present. 
A high affinity carrier system for the re-uptakP. of ACh was 
identified (Yamamura et al., 1972). It is suggested that 
the high affinity transport may be linked to the choline 
acetylation pathway. 
acetylated will not 
Therefore, substances which cannot be 
be picked up by this system. This 
supports the evidence that ACh is taken up by means of a 
8 
slow not a high affinity uptake system (Kuhar et al., 
1974). The modulation of the fast choline uptake system has 
been demonstrated. Collier et al. (1969) has shown that 
there is a significant increase in the rate of choline 
uptake following the invasion of nerve impulses into the 
nerve terminals. This higher rate of uptake may be linked 
to an increase in axoplasmic Na+ (Yamamura et al., 1973). 
Also, an increase in ACh release was linked 
stimulation of high affinity transport mechanisms 
et al., 1974). 
Axonal Action Potential 
to the 
(Collier 
An axonal action potential is a self-propagating 
wave. Its polarity is the reverse of the resting membrane 
potential. The triggering mechanisms depend upon the system 
analyzed: they can be generated by the activation of a 
sensory transducer, by a voluntary decision made at higher 
centers or by a stimulating electrode. In this study, the 
axons of the phrenic nerve involved arP principally 
-motoneurons. The a. -motoneurons range with respect to the 
diameter (9-20 .um) and conduction velocity (50-120 m/s) 
(Boyd et al., 1968). Conduction velocity is a temperature 
sensitive phenomenon, i.e., with decreasing temperature, 
there is a decrease in the velocity followed by a complete 
block (Paintal, 1965). 
For the first time, in the early 1950s, Hodgkin and 
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Huxley were able to identify by means of the voltage clamp 
method, the ionic species involved in action potential 
generation (Hodgkin and Huxley, 1952 a-d). They identifier! 
two primary currents, Na+ and K+. The first inward current, 
which reversed at +60 mV, was shown to be the Na+ current. 
The late currents, with an outward direction, reversing at a 
greater negativity than -60 mV, were K+ currents. They also 
showed the presence of a leakage current. Their work on the 
giant squid axon provided a framework for understanding 
voltage dependent changes in membrane permeability involved 
in the generation of the action potential. 
I n my e l i n at e d axon s , a v e r y s p e c i a l i zed reg i on , t he 
node of Ranvier, is a gap between tightly wrapped·, Schwann 
cells, measuring 1 11m and containing 100 times more sodium 
channels as the unmyelinated fibers. It is the only area of 
the axon which is exposed to the external environment. In 
their early work, Huxley and Stampfi (1949) showed that in 
the regions between the nodes, the current was very small 
compared to the currents near or at the nodes. This 
observation gave the impression of a current jumping from 
node to node, thus, the name saltatory conduction. 
There are many drugs that alter the action 
potential. Selective ionic channel blockers, like TEA, have 
different effects depending upon the mode of application. 
Extracellularly, TEA decreased the size of the K+ curr-ent in 
a dose dependent manner (Hille, 1967). Internally applied 
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TEA appeared to alter the kinetics of the K+ currPnt. 
interacting only with open ionic channels. This block wac; 
shown to be partially reversed by an increase in the 
external K+ (Armstrong. 1972). 
Na+ channels are blocked selectively by nanomolar 
concentrations of tetrodotoxin (TTX) and saxitoxin (STX). 
When internally applied, these drugs show no efficacy 
(Narahashi, 1971). Local anesthetics are effective in 
blocking Na+ currents. This block seems to be voltage 
dependent (Strichartz, 1973). It is believed that 
anesthetics must enter the membrane before they can exert 
their action, because quaternary derivatives of these 
compounds are effective only from the inside (Frazier et 
al., 1970). 
Toxins from the plant and animal kingdoms were found 
to play a role in altering gating processP.s. For example, 
scorpion venoms slow or abolish the Na+ channel 
inactivation, bringing about long duration action potentials 
(Koppenhofer et al., 1968; Narahashi, 1971; Witkop et al., 
1984). Other toxins, such as butrachotoxin, shift the 
voltage dependence and slow the kinetics of Na+ channel 
activation (Seyama et al., 1976; Khodorow et al., 1975). 
For many years, it was known that the Ca++ 
concentration had an effect upon the threshold of excitation 
in nerve action potential generation. Subsequently, some 
information has come to light regarding this phenomenon. By 
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means of voltage clamp experiments, it was shown that 
conductance-voltage curves for Na+ and K+ were shifted with 
different Ca++ concentrations (Hille, 1968). These 
experiments were used to estimate the amount of negative 
surface charge by using gating processes as detectors of 
electrical fields. The estimated density for negative 
charges about Na+ and K+ channels showed a trend pointing to 
3 times as many negative charges associated with Na+ as with 
K+ (Vogel, 1974). An increasing Ca++ concentration may be 
perceived in hyperpolarization of the membrane or an 
increase in the membrane's electrical field near the 
channels. This change in the electrical field by screening 
negative charges near the Na+ channels by Ca++, may alter 
the gating processes, leading to an elevated threshold of 
activation (Cahalan, 1978; Hille, 1985). Recently, the 
adaptibility of axons to various challenges has been 
investigated by comparing the myelinated to the unmyelinated 
axons. 
Non-myelinated fibers are considered to have uniformly 
organized membranes capable of impulse propagation. 
Myelinated axons, however, appear to have a very complex 
structure, which only now is understood in terms of its 
functional organization. The Schwann cells in the 
peripheral nervous system form compact, spirally arranged 
membranes with very high resistance and low tranverse 
capacitance. Thus, the only area capable of generating 
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ionic currents is the internodal region. These regions 
appear to be specialized in terms of their ionic channel's 
organization. Tritium-labelled saxitoxin, used to label Na+ 
channels, revealed that under the myelin sheath, the density 
of these structures decreases from 10 4/µm2 to less than 
25/.).lm 2 , according to the distance from the nodal region. 
Although there is growing evidence that voltage sensitive K+ 
channels might not be involved in classical repolarization 
in myelinated mammalian axons (Brisman, 1980), they might be 
involved in rapid deactivation of Na+ channels together with 
K+ carried leakage current, flowing through more selective 
voltage independent channels. The presence of voltage 
sensitive K+ channels is rare in the mature internodal 
region. 
injured, 
However, in the developing pre-myelinated or 
demyelinated axon, the presence of voltage 
sensitive channels is observed (Waxman and Foster, 1980; 
Chin et al., 1980). The contribution of K+ channels to 
action potential electrogenesis changes with development; 
during pre-myelination, action potential integrity is 
dependent upon the K+ channels. The sign i f i can c e of K + 
channels lessens with myelination. These observations point 
to the physiologic flexibility and complexity of the axonal 
membrane, action potential generation and propagation. 
There is also indirect evidence suggesting changes in axonal 
membrane fluidity. Bostock and Sears (1978) showed t-hat in 
axons demyelinated by means of Diphtheria toxin, there is 
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continuous uninterrupted conduction. The axon's adaptive 
response to demyelination, by Diphtheria toxin, is a return 
to the pre-myelinated state, as once present in early 
development, with Na+ and K+ channels spread throughout the 
demyelinated region (Coria et al., 1984). These 
reorganizations undoubtedly involve changes in the 
microviscosity of the membrane in the affected area: 
however, to date, there is no literature addressing this 
issue. 
Miniature Endplate Potentials (mEPP) 
Classically, there 
released 
response 
liberated 
from the nerve 
to an axonal 
spontaneously. 
are two ways by which ACh can he 
terminal; ACh can be released in 
action potential; and ACh can be 
Jn 1951, Fatt and Katz first 
described these spontaneous 
endplate potentials (mEPPs). 
were subthreshold in nature. 
potentials, or miniature 
They found that these events 
Their size was reduced by 
curare (d-tubocurarine) and increased by prostigmine. 
Temperature and osmotic pressure increase resulted in an 
increased frequency of mEPPs. A study of Na+ and Ca++ 
effects upon these events indicated their independence from 
Ca++. A reduction in Na+ concentration, however, decreased 
the size of the mEPPs. 
The amplitudes of mEPPs are distributed in the ~ormal 
fashion within a small range. Studies of various muscle 
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types in many different species, including man, show the 
above mentioned properties (see a review by Hubbard, 1973). 
Under normal conditions, the amplitude of mEPPs 
depends upon the input impedance of the muscle fiber, which 
1artially depends upon the diameter of the muscle fiher 
(Katz et al., 1957). When the muscle diameter decreases, 
the mEPP amplitude increases. Also, the amplitude of the 
mEPP can be enhanced by means of the inactivation of AChE, 
allowing more ACh molecules to interact with more ACh 
receptors. The location of a recording P.lectrode is of 
importance; e.g., one observes a decrease in the amplitude 
by moving the electrode away from the end-plate region 
(Ginsborg, 1960). The mEPP is considered to represent a 
quantum of ACh, an integral number released in response to 
the axonal action potential. It is widely believed that the 
quantal release, as observed in a single mEPP, corresponds 
to one vesicle (deRobertis, 1964). This led to the 
postulation of the quantal hypothesis (Fatt & Katz, 1952; 
del Castillo and Katz, 1954; Liley, 1956). Recently, 
electrophysiologists (Kriebel et al., 1976; Kriebel et al., 
1978) and biochemists (Israel et al., 1979) have challenged 
this hypothesis (for further discussion of the above topics, 
see the methods and discussion). In addition to ACh, the 
vesicle contains an acidic protein and ATP (Whittaker et 
al., 1979). This protein has been named 11 vesiculin 11 • At 
this time, it is not clear what physiologic functions may be 
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ascribed to vesiculin and ATP. 
The mEPPs frequency. a purely pre-synaptic phenomenon. 
can be influenced by many factors: increasing the Mg++ and 
reducing Ca++. reduces the frequency of mEPPs; but 
generally. this effect is less significant than that 
obtained with regard to the evoked release (Hubbard et al •• 
1968). It appears that divalent cations like Ba++. Sr++. 
Co++ and Mn++ are capable of substituting for Ca++ in its 
absence. In its presence. however. a competition between 
the bivalent ions is observed. resulting in a reduction in 
the mEPPs frequency (Elmquist and Feldman. 1966). An 
i n crease i n K + at the term i n a 1 ends • res u 1 t i n g i n 
depolarization. exhibits an increase in the mEPP frequency 
that is enhanced by a reduction in Na+. 
Many drugs can also increase the mEPP frequency. For 
example. cardiac glycosides. catecholamines. and 
phenobarbitone. all increase the frequency of mEPPs (Birks 
and Cohen. 1968; Kuba. 1970). Ca++ ionophores. like X-537A. 
also have a potentiating effect (Kita and Van der Kloot. 
1974). It is believed that this effect is mediated. at 
least in part. via an increase in intracellular Ca++. 
Venoms from different sources are found to be powerful 
ACh releasers. though they vary in terms of their mode of 
action. Some. such as the Black Widow spider venom. 
increase the frequency of mEPPs to the point of depletion 
(Longenecker et al •• 1970); whereas. others like Taiwan-
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banded Krait venom, produce a biphasic effect. The first 
phase is characterized by a rapid increase in the mEPP 
frequency followed, i n the second phase, by a decrease 
(Chang et a 1 • , 1979). The agents found to decrease mEPP 
amplitt1de a re numerous. They vary from toxins like 
Botulinum to endogenously occurring compounds like adenosine 
(Spitzer, 1972; Ginsborg and Hirst, 1972). 
Endplate Potential (EPP) 
According to the vesicular hypothesis, EPPs are 
composed of many unitary events (quanta) and are very 
similar in shape to mEPPs (Katz, 1969). The frequency of 
the EPPs is, of course, directly dependent upon the 
frequency of axon stimulation. The amplitude, however, 
depends upon a variety of factors. Boyd and Martin (1955) 
reported that the amplitude of EPPs decreases with an 
increase in the distance from the junction. This is related 
to the time course of the potential change which is 
determined by the passive electrical properties of the 
membrane (Fatt and Katz, 1951). The number of units 
composing EPPs were decreased with an increase in the 
concentration of Mg++ and a decrease in Ca++, leading to a 
smaller amplitude. An increase in the Ca++ concentration of 
the Ringer, resulted in an increase in the quantum 
content. Boyd and Martin (1955) also observed that EPPs are 
temperature dependent. In curarized muscle, lowering the 
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bath temperature decreased the amplitudes of the EPPs; 
however, in a Mg++ blocked preparation, the opposite effect 
was seen; i.e., the amplitude of the EPPs increased with a 
decreased temperature. Lowering the temperature also 
increases the half decay-time of the EPPs. 
The EPP's amplitude can be enhanced by increasing the 
quantal content; for example, cesium ions increase the 
amplitude of the axonal action potentials, thereby 
increasing acetylcholine release {Ginsborg et al., 1968). 
Drugs like tetraethylammonium, aminopyridines and guanidine, 
enhance ACh release by extending the duration of the axonal 
action potential {Koketsu, 1958; Horn et al., 1979). 
Another way of increasing the amplitude of EPPs and 
prolonging its decay-phase is by increasing the effective 
ACh concentration at the synaptic cleft. This may be 
accomplished using AChE-blockers. There are many compounds 
with the ability to inhibit AChE; they range from 
reversible, clinically-used 
potent, almost irreversible, 
D FP. 
Endplate Current {EPC) 
drugs, like neostigmine, to 
organophosphorus drugs, 1 i ke 
The recording of EPPs with an intracellular 
microelectrode provides a useful measure of the amount of 
acetylcholine released from the nerve terminal and some 
gross appreciation for the post-synaptic membrane integrity; 
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it is, however, less useful in studying the mechanisms by 
which ACh-receptor complexes cause ionic current flow. More 
useful tools, in this respect, are concentration jump 
relaxation, voltage jump relaxation, noise analysis and 
single channel patch clamp recording. All of these methods 
are used to analyze ionic channel activity either 
indirectly, i.e., concentration jump relaxation, or 
directly, single-channel patch clamp analysis. In this 
work, concentration jump relaxation or the recording of the 
end-plate current (EPC), which is achieved by means of the 
voltage clamp (Takeuchi and Takeuchi, 1959) was used. There 
are similarities and differences between EPCs, EPPs, mEPCs, 
and mEPPs. Some of these will be pointed out. 
The EPC amplitude is linearly related to the EPP 
amplitude in a narrow range, for example, in the amphibian 
neuromyal junction. This relationship holds up to 50 mA and 
15 mV, whereas in the mammlian preparation, this 
relationship is valid up to 25 mA and 10 mV (Mclachlan and 
Martin, 1981). The relationship between the holding 
potential and peak EPC amplitude is non-linear (Magleby and 
Stevens, 1972). In the case of elementary events (mEPCs), 
it was found that the linear relationship held (Anderson, 
1973). Hyperpolarization of the post-synaptic membrane 
results in a decrease in the synchrony of conductance 
initiation as a result of the slowing of the EPC's growth 
phase (Magleby et al., 1972); thus a decrease in the 
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amplitude is expected. 
As the temperature decreases, the amplitude of 
elementary events stays the same, while the amplitude of 
mEPCs decrease (Anderson and Stevens, 1973). Magleby and 
Stevens (1972) described the falling or decay-phase of the 
EPC in terms of a single, exponential time constant. 
Anderson and Stevens (1973) demonstrated that this decay is 
probably a measure of the randomly distributed lifetime of 
the ACh activated ionic channels, thus, suggesting that a 
change in the decay-time may reflect a change in the channel 
activity. This observation is supported by independent 
techniques, such as, noise analysis and patch clamp studies 
(Anderson and Stevens, 1973 & Neher and Steinbach, 1978). 
In accordance with this concept anticholinesterases enhances 
mEPC and EPC amplitudes (Gage et al., 1975). 
The dependence of the decay-time upon decreased 
temperature 
(Magleby and 
and hyperpolarization has been established 
Stevens, 1972; Gage et al., 1975); both of 
these effects increase the decay-time of the EPC. 
Generally, acetylcholinesterases, as it may be predicted, 
increased the decay-time of EPCs and mEPCs (Eccles et al., 
1942; Fatt and Katz, 1952). However, neostigmine was 
reported to shorten the decay-time (Kordas et al., 1975); 
whereas, physostigmine and OFP prolong it (Kordas et al., 
1975; Kuba et al., 1974). There is a long list of agents 
involved in altering the exponential decay-phase of EPCs and 
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mEPCs (for a recent review, see Lambert et al., 1983). Some 
agents shorten the exponential decay; for example, d-
tubocurarine, which acts in a voltage dependent fashion 
(Manalis, 1977), or pancuronium which prolongs the 
exponential decay and also alters its monophasic 
configuration to a biphasic configuration (Katz and Miledi, 
1978). Other compounds, like short chain alcohols, prolong 
the decay-phase without alteration of its exponential form 
(Gage et al., 1975). 
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PHARMACOLOGY OF THE NEUROMYAL JUNCTION 
Neuromyal junctions, both amphibian and mammalian, 
have been used extensively as models in studies of drug 
effect upon synaptic transmission. Most of the studies 
involve drugs with very specific actions, i.e., receptor or 
channel blockers and agonists. In the section on the 
physiology of the neuromyal junction, the author 
concentrated upon drug effects which may resemble the 
activity of PLC, used in this study, in order to speculate 
on the possible mechanisms involved in PLC activity. It is 
important, however, to mention, generally, other well 
described pharmacologic agents (for a review, see Karczmar, 
1 9 6 6 ; Bo wm a n , 1 9 8 0 ) • Th e re a re n o s p e c i f i c i n h i b i t o r s o f 
ACh synthesis. Some compounds show a weak or a relatively 
unspecific inhibitory action; these are alpha-keto acids 
(Nachmason and John, 1944), barbiturates (Marks, 1956) and 
nitrogen mustards (Barron et al., 1948). High and low 
affinity choline transports across the membrane, on the 
other hand, are inhibited by several compounds. The best 
known is hemicholinium (HC-3). All of the compounds, in 
this group, contain choline-like moieties, for which 
Schueler coined the term 11 hemicholiniums 11 • Besides being 
uptake blockers, some of these compounds also have post-
junctional effects, e.g. HC-3 has a curarie-like effect 
( Bo wm a n , 1 9 8 0 ) • 
Acetylcholine esterase inhibitors are numerous and 
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qualitatively have a similar effect. The difference lies in 
their activity as defined by their structure; for example, 
lipid solubility is a factor determining the peripheral or 
central effect of compounds, such as, neostignine and 
physostignine, respectively. Another important factor is 
the time-course of action, ranging from the short reversible 
inhibition of AChE, by edrophonium to the long-lasting, 
irreversible block by DFP. There also appears to be 
selectivity in terms of the cholinergic sites. Most of the 
compounds, with the exception of edrophonium, have an effect 
upon the parasympathetic neuro-effector junctions (for a 
good review see Karczmar, 1966; Miyamoto, 1978). 
Based upon the type of block produced, neuromuscular 
blockers can be divided into two groups: depolarizing and 
non-depolarizing. The first depolarizing blockers 
discovered were methonium compounds (Zaimis, 1954), followed 
by succinyldicholine, carbolonium, etc. Although the 
mechanism of their action is complex, these drugs interact 
with the nicotinic receptors while depolarizing the post-
synaptic membrane. For example, after opening the channels, 
decamethonium was shown to have a direct channel blocking 
effect (Adams and Sakman, 1978). 
Depending on their action upon endplate current (EPC), 
ACh activity inhibitors may be grouped into two classes: 
competitive antagonists, such as d-tubocurarine, which 
reduces the amplitude of the EPC but does not alter its 
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course (Albuquerque et al., 1978) and ncn-competitive 
allosteric antagonists, such as belladonna alkaloids (Adler 
et al., 1976), local anesthetics (Adams, 1975', etc., that 
alter both the amplitude and the time-course of the EPC. 
They also were found to alter the synaptic cu~rent-voltage 
relationship. 
In describing the pharmacology of the neuromuscular 
junction, one cannot help but mention the phenomenon of 
desensitization, described first by Katz and Thesleff 
(1957). Briefly stated, with repeated application of the 
agonist, there appears to be a diminution ~f the post-
synaptic signal. On a microscopic level, the deactivation 
of the ionic channels appears to be analcgous to Na+ 
inactivation; but probably, what this invoives is the 
multiplicity of unresponsive states of those prcteins formed 
slowly as the result of stimulation and that recover only 
during rest. This has been shown by both the conventional 
voltage clamp method (Feltz and Trautmann, 1982) and by 
single channel measurements (Sakmann et al., 198u). 
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HISTORY OF PHOSPHOLIPIDS 
The fir$t observation implicating phosphorus as being 
bound to fatty substances was made in 1811, by L.N. 
Vaugeulin, as he investigated substances extracted from the 
brain; however, the true father of phospholipid chemistry is 
J.L.W. Thudichum as he carried out the fundamental work on 
the brain's chemical constitution. He isolated and 
attempted to classify many phospholipid fractions on the 
basis of their nitrogen-phosphorus ratio. Later, many of 
the substances which he separated from the brain were shown 
to be mixtures. 
From brain tissue, Thudichum isolated a phospholipid 
which he designated as sphingomyelin. He was able to 
char~cterize it in terms of its constituents--mainly, the 
bases sphingosine and choline in addition to phosphoric acid 
and fatty acid. He also argued that 11 protagan 11 was not a 
distinctive substance but rather a mixture. Some years 
later, he was proven correct, when in 1927, Maclean 
discovered that "protagon" was a mixture of sphi ngomyel in 
and a cerebroside. 
The knowledge of phospholipids progressed slowly 
because of difficulties with fractionation, the absence of 
structural information and the popularity of carbohydrate 
research. In the late 1950s, there was a revitalization in 
phospholipid research; first, because of improvements in 
techniques, but more importantly, because lipids became 
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fashionable. With the enhanced interest in membranes and 
their composition, it became obvious that many membranes 
consisted largely of phospholipids and that phospholipid 
metabolism had to be elucidated. We now know that lipids 
and related compounds are essential in the functioning of 
the membrane's machinery; moreover, it is becoming apparent 
that phospholipids play a role in the transport of ions 
across membranes and serve as substrates for the de novo 
synthesis of acetylcholine. 
Action of Phospholipases 
The enzymatic action of phospholipases upon 
phospholipids is illustrated in Figure O. 
The structure of phospholipids is based on a three 
carbon backbone orginating from glycerol. These carbons are 
numbered from three to one, starting with the phosphate-
attached carbon. The "X" in Figure 0 represents any of the 
typical radicals. The terminology of phospholipids is 
derived from the characteristic radical; for example, if "X" 
is choline, then the phospholipid in question is named 
phosphatidylcholine. 
The nomenclature of phospholipases has been 
standardized. The enzymes affecting the ester bond on 
carbon-1 (Cl) and carbon-2 (C2) are referred to as 
phospholipase Al (PLAl) and phospholipase A2 {PLA2), 
respectively. Two types of phospholipases affecting the 
26 
FIGURE 0 
Structure of a phospholipid with specific phospholipase 
actions upon it. 
R1 = Phospholipid moiety. 
R2 = Phospholipid moiety. 
X = Non-phospholipid moiety. 
PLA1 
0 
11 
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chain originating from C3 act similarly to PLAl and PLA2 by 
cleaving ester bonds and liberating phosphc.te containing 
compounds (P-X). In the case of phospholipasc D (PLO), its 
action upon a phospholipid results in the liberation of the 
x-side chain, leaving behind phosphatidic acid. 
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GENERAL BIOCHEMISTRY OF PHOSPHOLIPASES 
Phospholipases Al and A2 
A short review of work carried out to establish the 
efficacy and properties of phospholipases follows: 
Phospholipase Al and A2, enzymes which hydrolyze ester 
linkages on Cl and C2, respectively, of the 
diacylglycerophosphoryl base, have been purified from many 
sources, e.g., snake and bee venoms, bacteria and many 
mammalian tissues. In 1971, Scandella purified an enzyme 
with a specific PLAI activity, which was 1,200 times more 
active than the original material of Escherichia coli where 
PLAI was present in the outer membranes of the bacterium; 
this enzyme was found to have a molecular weight of 
approximately 60,000. It is inhibited by Na+ and activated 
by Ca++ (this is not true for all species of PLAI; see 
below). Its optimal pH is 8.0. Raybin et al. (1972) 
studied an enzyme (PLA} specific for the carbon-I position 
of phospholipids which was obtained from the spores of 
Bacillus megathenium. He purified the enzyme 170 times and 
found no need for Ca++ as an activator. 
Phospholipase Al is widespread throughout mammalian 
tissue, as it is found in practically every subcellular 
fraction of the cell {Gatt et al., 1973). The properties of 
PLAI differ depending on its location and the pH optimum. 
For example, brain PLAI is heat labile and does not exhibit 
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Ca++ dependence for its activation; while PLAl from guinea 
pig pancreas has a pH optimum of 6.0 and is inhibited by 
Ca++ (White et al.. 1971). Rat liver PLAl, found in plasma 
membranes and microsomal fractions, exhibited a pH optimum 
of 9.0 and was found to be activated by Ca++ (Newkirk et 
al., 1971), as does PLAl derived from E. coli. 
PLA2 is probably the most studied lipase. Depending 
on the source, 
(Salach, 1971) 
its molecular weight may vary from 8,400 
to almost 30,000 (Wells et al., 1969). 
Pancreatic PLA2 has been completely sequenced; it is a 
single chain protein with six disulfide bridges (deHaas et 
al., 1971). At the C-end of the chain, there is a 
concentration of basic amino acids whose cleavage renders 
this enzyme inactive (Scanu et al., 1969). It has been 
demonstrated that pancreatic PLA2 has a Ca++ requirement for 
activation (Augustyn, 1970). However, Vipora rusellii 
phospholipase was found to be inhibited by Ca++ and other 
divalent cations (Slotboom, 1970). The optimal substrate 
for PLA2s depends on the source of the PLA2. PLA2 from 
Laticauda semifasciata exhibits a high specificity for 
phosphatidylethanolamine as a preferred substrate (deHaas, 
1968). The properties of PLA2s obtained from several 
mammalian sources have been described, including PLA2s of 
the arteries, heart muscle, and liver mitochondria of 
different species. It appears that all of these enzymes 
have a basic pH optimum activated by Ca++ and have an 
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affinity for phosphatidylethanolamine as a substrate. 
However, enzymes located in the lysosomal fraction of liver, 
and human and rat brain have pH optima in the acidic range 
and are inhibited by Ca++. More specific localization 
studies show that rat hepatocytes contain mitochondrial PLA2 
with a basic pH optimum and Ca++ dependency; while it is 
primarily localized in the outer membrane (Nachbaur, 1972), 
there also seems to be significant activity present in the 
inner membrane. Many mammalian tissues contain both PLAl 
and PLA2; in the case of rat 1 i ver plasma membranes, PL Al 
and PLA2 are activated by Ca++, but the relative activity of 
these enzymes is dependent upon the substrate used. PLA2 
had a high specificity for phosphatidylglycerol, whereas 
PLAl was more active in the presence of 
phosphatidylethanolamine (Newkirk, 1973). 
Phospholipase C (PLC) 
In 1971, Zwaal et al. purified PLC from Bacillus 
cereus. This purification generated a product with a 
molecular weight of 21-25,000 Daltons. This enzyme required 
Ca++ for activation. PLC did not hemolyze erythrocytes, but 
could degrade phospholipids of erythrocyte ghosts (Gatt, 
1973). Casu et al. (1971) prepared a purified form of PLC 
from Clostridium perfringens: its molecular weight was 
estimated at 90,000; and its activity was dependent on Ca++ 
ions. This PLC differed from the enzyme derived from 
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Bacillus cereus in that it had strong hemolytic activity. 
PLC degraded phospholipids present in fragments of purified 
my e 1 i n ( Mc Il w a i n , 1 9 7 1 ) ; a s mu ch a s 7 0 % t o 9 0 % o f 
phosphatidylethanolamine, phosphatidylcholine and 
sphingomyelin was degraded; but only a small amount (14%) of 
phosphatidylserine was affected. Koeugh {1972) found PLC in 
the microsomes and cytosol of bovine brain. Hostetler et 
al. (1980) carried out a very extensive study of PLC 
involving the analysis of many rat tissues: adipose tissue, 
brain, diaphragm, duodenum, heart, ileum, jejunum, kidney, 
liver, lung, skeletal muscle and spleen. They found that 
all of these tissues exhibited PLC activity. These enzymes 
appeared to have optimal activity in an acidic pH. 
Phospholipase O (PLO) 
For a long time, the only source of PLO was from plant 
homogenates such as cabbage, sugar beets, 
cottonseed and peanut seed (Kates et al., 1963). 
spinach, 
PLO from 
these sources showed a broad range of activities toward 
phospholipids; in order of decreasing hydrolysis rate these 
phospholipids were lecithin, phosphatidylethanolamine and 
phosphatidylserine. This enzyme exhibited optimal activity 
at an acidic optimum pH; but there was variability in this 
respect, as the true optimum depended on the source (Einset 
'et al., 1958; Tookey, 1956). It has been shown that PLO 
requires Ca++ for activation and that other divalent cations 
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cannot substitute for Ca++. Besides havinJ hydrolytic 
properties, as described above, PLO a 1 ; o exhibits 
transferase activity which, in the presence of Jlcohols such 
as glycerol, methanol and ethanol, aids in the transfer of a 
substrate, i.e., lecithin or phosphatidyletn<nolamine, to 
the acceptor alcohol (Yang et al., 1967). PLJ is present in 
mammalian tissues; e.g., Chalifour, et al. 980) reported 
the presence of PLO in rat brains. They pu,..·fied this PLO 
and showed that it possessed dual activity, i.~., hydrolytic 
and transferase properties. It has been reported that 
activation of PLO from rat brain and lung microsomes was 
undetectable without the presence of detergents, like bile 
acids or unsaturated fatty acids (Chalifour et al., 1980). 
Chalifour et al. (1982) carried out further studies the 
activation phenomenon as they investigated the activity of 
PLO in many rat tissues: brain, epididymal fat pad, heart, 
intestinal mucosa, kidney, liver, lung, skeletal muscle, 
spleen and testes. As measured by the formation of 
phosphatidic acid from H3-I-phosphatidylcholine, all of 
these tissues exhibited PLO activity. In addition, it 
became apparent that the activation of PLO could be 
accomplished by means of unsaturated, long chain fatty acids 
naturally occurring in its environment. 
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Effects of Phospholipases Al, A2, D and C on Tissue Models 
In 1966, Albuquerque and Thesleff studied the effects 
of phospholipase C on the electrical properties of skeletal 
muscle membrane. They used two models, innervated and 
denervated skeletal muscle of the rat. They also compared 
the action of PLC on slow versus fast muscle in the chicken 
and rat. Considering the resting membrane potential, input 
resistance, action potential and acetylcholine sensitivity, 
they found that with doses higher than 1.5 pg/ml, there was 
a significant fall in the membrane resistance over time. In 
the rat and the chicken, the most significant effect was 
found in the case of the fast muscle. Denervated muscle, 
whether fast or slow, was more resistant to the effects of 
phospholipase-C on membrane resistance. Within one hour 
after applying 1.5 g/ml of PLC, the action potential was 
found to be totally and irreversibly blocked; innervated and 
denervated muscles were equally sensitive to this effect of 
PLC. There was no effect on the input resistance {IR) and 
the resting membrane potential {RMP). Acetylcholine 
reduced sensitivity was 
abolished the electrical 
Albuquerque Subsequently, 
with a PLC concentration which 
excitability of the membrane. 
et al. {1967) investigated the 
interaction of divalent cations with PLC treated mammalian 
skeletal muscular membrane. PLC's inhibition of action 
potential generation was somewhat similar to the action of 
local anesthetics {Shanes et al., 1959); but it differed in 
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that PLC had a pronounced effect upon the RMP. The 
investigators found that after PLC application, washing did 
not restore action potential generation. However, by 
increasing the calcium concentration from 2 mM to 15 mM, 
there was repolarization of the membrane followed by 
restoration of the action potential. Analysis of the 
latter, by means of low sodium Ringer perfusion and a 
specific sodium channel blocker (tetrodotoxin) indicated 
that this action potential was sodium generated. Calcium's 
effects were antagonized by ions such as caesium and 
rubidium. 
Watson et al. (1976), in their investigation of the 
denervation sensitivity phenomenon, found that PLC (5 
JJg/ml) and phospholipase 0 (PLO 5 ug/ml) had a similar 
effect on muscle contraction as did the homogenate, 2 ~g/ml, 
of the denervated muscle. By investigating the contraction 
response of skeletal muscle to ACh applied in the bath, they 
observed an approximately two-fold increase in contracture 
with denervated muscle cytosol, PLC and PLO. Phospholipase 
A and other enzymes like trypsin, collagenase and protease, 
were shown to have no effect. Also, to exclude the 
possibility that the effect might be due to the 
anticholinesterase activity of PLC or PLO, ACh was 
substituted with carbachol; it was found that there was no 
difference in the effect of PLC or PLO on either the ACh or 
carbachol responses. The RMP was monitored throughout the 
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experiment and there was no significant effect of PLC or PLO 
on the RMP. The authors ascribed the potentiation effect of 
PLC, PLD and cytosol to their interaction with membrane 
phospholipids resulting in the unmasking of spare receptors. 
Harborne et al. (1978) directly addressed the issue of 
PLC, cytosol and pepsin-induced increase in ACh and carba-
chol sensitivity being related to the availability of spare 
receptor. They too measured isometric muscle contraction 
generated by ACh perfusion and monitored the RMP. 
Harborne et al. (1978) incubated the preparation in 
a -bungarotoxin at a concentration of .001 g/l. 
Subsequently, a block of the response to ACh was observed. 
The PLC treatment followed. It was observed that there was 
a recovery of the response; but its magnitude was 28% less 
than the amplitude of the ACh response of the controls. In 
the absence of an a -bungarotoxin block, PLC treatment 
potentiated the ACh response by 104% above the control. 
These results seemed to support the spare receptor 
hypothesis. The drug concentrations and the effects 
obtained by these two groups of investigators cannot be 
readily compared because the units were expressed not in 
pg/ml but rather in units of activity per ml (u/ml). 
The studies mentioned above concerned the post-
junctional effect of PLC and PLO. Using microelectrode 
techniques 
frog, Ohta 
with the sciatic nerve/sartorius muscle of the 
and Karczmar (1981) and Ohta et al. (1981) 
37 
explored both the pre- and post-synaptic effects of PLC. 
They found that the RMP and the membrane resistance did not 
change with a drug concentration of .1-1 )Jg/ml; however, at 
a concentration of 3 ~g/ml, the RMP and input impedance were 
reduced; a reversal of this effect was not observed within 1 
hour of washing. The effects of PLC upon the excitatory 
post-synaptic current (EPC) were dose and time dependent; 
i.e. a higher concentration required less time for the onset 
of the peak drug effect. The increase in the response was 
in the range of 10% as compared to the control. However, 
inhibition of the response was observed with continuing drug 
application. Similar effects were observed in the 
experiments involving the analysis of the excitatory post-
synaptic potential (EPP). It was also noted that the shapes 
of the waveforms (EPC, EPP} were affected by the drug: while 
the upstroke was not changed, the decay was prolonged. The 
investigation of the ACh potential pointed to some 
differences between the effects of PLC on the EPP, EPC and 
ACh response; the 'augmentation effect on the ACh potential 
was not as extensive. The peak influence of PLC upon the 
ACh potential compared to the EPP differed temporally. 
Also, there was no secondary diminution of PLC induced 
potentiation. When the effect of PLC on the spontaneous 
release of ACh was investigated, it was observed that PLC at 
a concentration of .3 JJg/ml significantly increased the 
frequency of mEPPs by 105%; it increased the amplitude of 
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mEPPs by 20-30%. The time course of the effect was very 
similar to that of the effect of PLC on the EPP and EPC. 
Calculated by means of the failure method, the quantal 
content showed an augmentation; this effect was reversed 
with washout. An investigation of Ca++'s role in the effect 
of PLC was conducted; it was found that PLC had a 
potentiating effect in low, normal and high Ca++; but, the 
highest increase occurred in the low Ca++ solution. When 
drugs effecting Ca++ flux such as dantrolene were used, PLC 
did not induce potentiation as it prevented PLC action on 
the EPP and EPC amplitude; also, dantrolene prevented the 
augmenting effect of PLC on the quantal content. Verapamil 
inhibited the quantal content augmentation observed with PLC 
and blocked the potentiation of EPC and EPP amplitudes. 
Finally, used in low concentrations verapamil decreased the 
duration of PLC augmentation. The study also demonstrated 
the Ca++ dependence of PLC facilitation on the spontaneous 
and evoked ACh release. It was suggested that PLC, on the 
one hand and dant rol ene and verapami l on the other had 
opposing effects upon Ca++ involvement in neurotransmitter 
release phenomena. 
The _earlier studies, (Nelson, 1958; Narahashi and 
Tobias, 1964) in which crude preparations of PLC were used 
upon frog nerve fiber and lobster giant axori, showed that 
PLC caused gradual membrane depolarization and an eventual 
block of the action potential conduction. Rosenberg and 
39 
Condrea {1968), by using a more purified preparation of PLC 
from Clostridium welchii in a concentration of 90 u/ml for 
30 minutes, found that there was no si gni fi cant change in 
the conduction and shape of the action potential. They 
concluded that axonal conduction and membrane permeability 
can be maintained in the presence of extensive phospholipid 
s p 1 i t t i n g ; 1 0 0 % s p h i n go my e 1 i n , 8 4 % 1 e c i t h i n a n d 5 0 % 
ethanolamine. Depending on the experimental condition, PLC 
from Clostridium welchii could eliminate from 85-100% of the 
phosphorylated bases with 87% to 93% of the diglycerides 
remaining within the membrane {Rosenberg, 1970). This 
result suggests the role of phospholipids play in the 
function of axonal membranes • 
effect when applied to the 
{Rosenberg and Condrea, 1968). 
However, purified PLC had no 
outside of the squid axon 
Internal application of this 
purified enzyme depolarized the membrane and blocked signal 
conduction {Tasaki and Takenaka, 1964). Hinzen (1977) 
studied the effects of PLC and PLA upon Aplysia neurons by 
means of the voltage clamp technique. He analyzed the ionic 
conductance and currents resulting from an internal 
application of pure PLC and PLA. He found that PLA rapidly 
decreased the membrane potential and resistance and markedly 
depressed the peak transient current; there was little 
effect upon the late, outward current. The PLC that was 
used was obtained from two sources: PLC obtained from 
Bacillus cereus, caused strong hyperpolarization, decrease 
, 
40 
in the membrane resistance, and marked increase in the late, 
outward current; while PLC obtained from Clostridium welchii 
caused a marked increase in the resting membrane resistance 
(RMR) as well as hyperpolarization. The external 
application of these enzymes was ineffective. The 
conclusion drawn from the data was that phospholipases, from 
different sources, have distinct pharmacological actions 
which differ depending on the preferred substrate of the 
phospholipase in question. 
Ionic Mechanisms Involved in PLC Activity 
The effects of PLC originating from Clostridium 
welchii on the frog skin was examined by Yorio et al. 
(1976), who found that at 50 JJg/ml PLC exerted a reversible 
activating effect upon transepithelial Na+ transport as 
reflected by means of the potentiation of a short circuit 
current. This PLC activity was abolished by means of 
simultaneous perfusion with amilioride (.0001 M), a specific 
inhibitor of Na+ transport across such epithelia (Bentley, 
1968). Yorio et al. (1976) also found that aldosterone 
appeared to have an additive effect with PLC. The conclu-
sion drawn from the data implicates this highly specific 
enzyme, PLC, in a selective activity promoting reversible 
activation of Na+ influx. In 1983, Philipson et al. 
investigated the effects of PLC obtained from both sources, 
i.e., Clostridium perfringens and Bacillus cereus, upon 
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cardiac sarcolemmal vesicles. Sarcoplasmic vesicles loaded 
with Na+ were exposed to PLC, 0.25-5 u/ml; then, the 
vesicles were exposed to a Ca++ uptake medium, containing 45 
mM CaCl 2• The Ca++-Na+ exchange reaction was stopped by 
adding KCl and LaC1 3• Thin layer chromatography was used to 
analyze the phospholipids. Electron microscopy was also 
performed. The results indicate that both types of PLC have 
an activating effect upon Na+-Ca++ exchange. This effect 
differed quantitatively depending on the origin of the 
enzyme. The enzyme obtained from Clostridium perfringens 
had a greater effect upon the Na+-Ca++ exchange than that 
obtained from Bacillus cereus. There was also an increase 
of passive Ca++ flux with the former. The analysis of 
phosphol ipids before and after PLC treatment revealed that 
the main substrates for the enzymatic activity were 
phosphatidylcholine, phosphatidylethanolamine and 
sphingomyelin, while other phospholipids, i.e., phospha-
tidylserine and phosphatidylinositol were left relatively 
intact. Electron microscopy revealed gross changes in the 
PLC treated vesicles. The authors expressed their surprise 
that "such severe structural damage can demonstrate enhanced 
transport activity." 
PLC has also been tested with respect to additional 
systems and it was found to inhibit the activity of several 
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transport enzymes, for example, Na+-K+-ATPase (DePont, 1978) 
of red blood cells, Ca2-Mg0 2-ATPase (Roelofsen, 1977) of the 
sarcoplasmic reticulum and K+-H+-ATPase (Schrijen, 1981) in 
gastric cells. 
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MEMBRANE LIPIDS AND PROTEINS 
Membrane Lipids and Fluidity 
In reviewing the literature concerned with the 
physical properties of membranes, such as fluidity, 
microviscosity and ordering versus disordering, one has a 
great deal of difficulty understanding the true significance 
of the descriptive terms above. It seems that fluidity is 
an all encompassing term. Fluidity describes the diffusion 
of molecules in a lateral, as well as, transverse direction, 
the flexibility of acyl chains and the rotational movement 
of proteins; whereas, microviscosity refers to a very small 
portion of the membrane i.e., the environment about the 
receptor proteins. The terms ordering and disordering 
appear to reflect the functional state of the membrane; for 
example, an increase in fluidity corresponds to ordering 
rather than disordering. 
Several types of investigative techniques are used in 
studying the membrane. First, electrophysiologic methods, 
though indirect, are a more physiologic way of measuring the 
effect of drugs upon lipid membranes (Gage et al., 1974). 
Second, a biochemical method of investigation involves the 
use of a probe in the form of a potentially excitable 
substance capable of entering into the membrane. This probe 
can be of any chemical structure as long as it will respond 
with motion to activation, e.g., by a magnetic field. 
44 
Another method used is electron-spin-resonance. In this 
method, spin labels are derived from a natural memhrane 
component to which a nitroxid group is attached. Still 
another method is the fluorescence-polarization technique; 
in this case, a membrane-bound dye, excited by polarized 
light, emits a light pattern; the amount of light emitted 
depends upon the fluidity of the membrane, i.e., a reduction 
in emission means increased fluidity. These studies do not 
evaluate the functional integrity of the membranes, but 
rather, directly measure their physical state. 
Fluidity is influenced by the chemical composition of 
the membrane. Cholesterol has been shown to be one of the 
main lipid rigidifiers in natural membranes {Shinitzky et 
al., 1976). Cholesterol associates more readily with some 
lipids than others; for example, sphingomyelin and 
cholesterol have a greater affinity for each other than 
lipids like phosphatidylcholine {Dekruijff et al., 1974). 
The cholesterol/phospholipid ratio was shown to be a good 
index of membrane fluidity with cholesterol being a 
rigidifying moiety {Cooper, 1977). 
During membrane biogenesis, the selection of saturated 
and unsaturated fatty acids in the membrane structure 
contributes to the degree of membrane fluidity. This 
structure can then be modified by enzyme "desaturases" which 
can increase or decrease the number of double bonds (Oshino 
et al., 1972) and modulate the length of the fatty acids 
''" 
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(Dickens et al., 1982). The first insertion of one double 
bond into a fully saturated fatty acid has a much greater 
fluidizing effect than any subsequent insertions (Stubbs, et 
al., 1981). 
Individual phospholipids, having varied physiochemical 
properties, contribute differently to the fluidity of 
membranes. For example, lecithin contributes to 
fluidization, whereas sphingomyelin contributes to 
rigidification (Shinitzky, 1974). Phosphatidylethanolamine 
is another membrane rigidifier; however, when it is 
methylated by membrane bound enzymes to form 
phosphatidylcholine, membrane fluidity increases (Hirata and 
Axelrod, 1980). Other lipids like phosphatidylserine and 
phosphatidylinositol are relatively unsaturated and may be 
compared to lecithin (Shinitzky et al., 1979); whereas 
s phi n go g 1 y co 1 i pi d s a re s i mi 1 a r to s p h i n go my e l i n a n d ca n be 
considered as lipid rigidifiers. Synaptic membranes, as 
compared to others, have a lower cholesterol/phospholipid 
ratio, a higher lipid/protein ratio and a higher ganglioside 
level (Dod et al., 1968). Depending on the type of 
preparation, the composition of the synaptic membranes vary 
greatly in terms of their specific phospholipids. For 
example, the quantity of phosphatidylserine varies from 8% 
(Harris, unpublished observation) to 18% (Hitzemann et al., 
1983). 
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The phospholipids of the synaptic membranes appear to 
be asymmetrically distributed, with phosphatidylcholine 
localized at the outer surface, and phosphatidylethanolamine 
as well as phosphatidylserine predominantly on the inner 
surface (Fontaine et al., 1980). 
Proteins of the Membrane 
Proteins embedded in the membranes may be divided into 
two types, integral proteins and peripheral proteins. These 
two types differ in several ways: Although peripheral 
proteins have a relatively consistent molecular weight, 
integral proteins vary greatly in molecular weight (Lenar, 
1970). Integral proteins are assumed to be critically 
involved in the structural integrity of the membrane and are 
difficult to dissociate from the membranes. They are also 
found to protrude into one or both aqueous phases. On the 
other hand, peripheral proteins are easily dissociated after 
treating membranes with mild chelating agents, and when 
dissociated, are totally free of lipids (Singer & Nicolson, 
1972). 
The position 
thermodynamic control 
of a membrane 
(Tanford, 1978). 
protein is under 
Hydrophobic forces 
maintain the protein within the membrane while hydrophilic 
forces pull it out. These two membrane forces combine to 
establish the protein's position of equilibrium. 
Conceptually, altering the strength of either one of these 
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forces will lead to a modification in the protein position 
within the membrane, exposing it to the aqueous phase or 
hiding it in the lipid phase. Membrane modification can 
lead to observable changes in the protein's behavior as it 
was noted by Borochov and Shinitzky (1976). They formulated 
a "vertical displacement hypothesis" which states that 
rigidification of the membrane results in the vertical 
displacement of the membranes towards the aqueous side. 
Within the membranes, other protein mobilities include 
the lateral and the rotational diffusions. A substantial 
portion of membrane proteins may appear immobile (Shinitzky, 
1983); however, these proteins can move when associated 
with metabolic processes (Edelman, 1976}; or for example, 
micro-aggregation of receptors in the case of the hormone-
receptor interaction (Schlessinger, 1980). Rotational 
diffusion of membranes is related to the immediate 
environment of the lipids. Bienvenue et al. (1977) has 
shown, using choline esters of spin-labelled fatty acids in 
a preparation of the electric organ of a Torpedo, that 
despite a highly clustered organization of proteins in the 
post-synaptic region, there is lipid-mediated fluidity. 
This fluidity may be effected by changes in microviscosity. 
Membrane Fluidity and Proteins 
Several studies have addressed the question of how 
fluidity effects the membrane receptors. Generally 
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speaking, the receptors involved in neuronal communication 
are most effected by changes in membrane microviscosity 
(Heron et al., 1981). Ligand binding studies have shown 
that in crude, mouse forebrain membranes, when the fluidity 
of the membrane was increased by incubation with lecithin, 
the binding was decreased; whereas in the case of 
rigidifying treatment with cholesterol, the binding 
increased (Hershkowitz, 1982). Changes in the membrane 
potential were observed to alter membrane fluidity with 
depolarization, decreasing viscosity 
and increasing viscosity with 
(Corda et al., 1982) 
hyperpolarization 
(Georgescauld et al., 1978). 
More 
fluidity 
permanent 
were observed 
rigidifying 
in aging. 
changes 
These 
in membrane 
changes were 
associated with an alteration in the constituents of the 
membrane. Si gni fi cant increases in cholesterol, 
sphi ngomyel in and glycosphi ngol i pi ds were observed (Rouser 
and Yamamoto, 1968). Also, there were changes in the degree 
of saturation of the lipid chains (Hubbard and Garrett, 
1980). 
Drugs and membrane fluidity 
Many drugs .have been investigated in terms of their 
effects on membrane properties, i.e., its organization. 
General anesthetics, like halothane and methoxyflurane, were 
shown to have disordering effects on the membranes 
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(Mastrangelo et al., 1978). Local anesthetics and other 
drugs showed varied effects depending on the type of 
membrane preparation (Neal et al., 1976) and drug used 
(Butler et al., 1973); for example, xylocaine exerted weak 
disordering effects on the membranes of RBCs (Hubbell et 
al., 1970) while other local anesthetics had no effect upon 
synthetic membranes and liposomes (Rosenberg et al., 
1977). Barbiturates and related drugs were shown to have a 
biphasic effect in terms of their action on the membrane. 
This effect was membrane-content dependent; for example, in 
low cholesterol membranes, chlorpromazine had an ordering 
effect; whereas in high cholesterol membranes disordering 
occurred (Pang et al., 1978). Normal, branched and 
secondary alcohols of up to 8 carbon units had a disordering 
effect upon membranes. Ethanol, because of its importance 
in the everyday life of many members of the population, has 
been studied extensively. Using the techniques described 
above, it was shown that ethanol generally has a disordering 
effect upon membranes (Chin et al., 1977; Harris et al., 
1980). It was shown by Chin et al. (1981) that the 
disordering properties of ethanol can be antagonized by 
cholesterol, suggesting that ethanol may have a greater 
effect upon fluid membranes. Chin et al. (1978) showed also 
an increased cholesterol content in the synaptic membranes 
of mice chronically treated with ethanol. In addition, 
myelin, as compared to synaptic membranes, was sensitive to 
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ethanol treatment (Harris et al., 1982). A hypothesis has 
been developed which states that alcohols have a 
preferential effect upon fluid membranes. Chronic 
administration may lead to rigidification of the membrane's 
structure through a ·change in the lipid to cholesterol 
ratio. 
Electrophysiologic studies of general anesthetics, 
local anesthetics, barbiturates and alcohols of different 
chain length, upon synaptic membranes, directed at relating 
electrophysiology and membrane phospholipids have been 
extensive (Beam, 1976; Torda et al., 1976; Gage et al., 1975 
and Gage and Hammil, 1981). The general effect of these 
compounds is dose and lipid solubility dependent. A 
decrease in the amplitude and increase in the rate of decay 
was observed in the synaptic signals, MEPPs and EPPs. Some 
interesting observations have been made by Gage et al. 
( 1 9 7 5 ) i n st u d y i n g t he effect s of et ha no 1 upon n e u r o my a 1 
transmission. They observed a prolonged lifetime of 
endplate channels expressed by the prolonged miniature 
endplate current's (EPC) decay-time. They proposed that the 
closing of open ionic channels was slowed. 
these findings to alcohol's interaction 
lipids, more specifically, to changing 
They attributed 
with membrane 
the membrane's 
dielectric constant through its incorporation into the lipid 
bilayer. 
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PURPOSE 
Phospholipase C (PLC) is ubiquitous in mammalian 
systems (Hostetla, 1980}. Its functional importance is not 
clear; biochemically, it is a specific enzyme involved in 
cleaving the diester bond on the third carbon in the 
phospholipid moiety. Hokin and Hokin (1954) discovered that 
P32 is incorporated into phosphatidate as a result of 
acetylcholine (ACh) and noradrenaline (NE) stimulation 
(Hokin, 1969). This discovery directed 
towards a hypothesis postulated by Michell 
investigators 
(1975), which 
suggests that receptor-stimulated breakdown of 
phosphatidylinositol via PLC might be implicated in a 
general mechanism of increasing cytosolic Ca++ 
concentration. Other inve~tigators proposed that PLC may be 
involved in unmasking spare receptors (Watson et al., 1976 
and Harborne et al., 1978). Ohta and Karczmar (1981) 
investigated these hypotheses in the amphibian neuromyal 
junction (NMJ). They found that in this preparation PLC has 
a complex action as pre- and post-synaptic effects were 
seen. In addition, they found that PLC had an effect on the 
membrane's calcium permeability. They hypothesized that 
this result was due to an alteration in membrane fluidity. 
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The working hypothesis of this thesis is based upon 
these facts and/or assumptions: 
1) Phospholipids are an integral part of neuromyal 
membranes. 
2) Phospholipids are closely associated with 
proteins. 
3) Receptor-ion channel complexes are made of 
proteins embedded in the lipid layers. 
This then leads to the hypothesis that alterations of 
the membrane lipid structures should have an effect upon the 
functional integrity of a system. 
Working Hypothesis 
Hydrolysis of the phospholipids in the pre- and post-
synaptic mammalian membranes will result in an alteration of 
transmission at the neuromyal junction. Phospholipase C, an 
enzyme that has a wel 1-documented effect on phosphol i pi ds, 
and appropriate electrophysiological methods will be used as 
tools in examining this hypothesis. 
Experimental Goals 
1. To observe if PLC from Clostridium welchii has an 
effect upon the mammalian NMJ affecting neuromyal 
transmission. 
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2. If the above is true, investigate the effect of 
PLC on pre- and post-synaptic indicators of 
neuromyal transmission. 
A. Pre-synaptic effect evaluation 
1. Extracellular compound axonal 
potential recording 
2. Intracellular recording 
a. mEPP frequency 
action 
b. quantal content evaluation by two 
methods: 
i) low Ca++/high Mg++ 
ii) cite-induced half-block 
B. Post-synaptic effect evaluation 
1. Dose response relative to RMP 
2. Effect of PLC upon 
a. EPP amplitude 
b. EPP waveform, i.e. rise and 
decay-time 
c. EPC amplitude 
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d. EPC waveform, i.e. decay-times 
e. mEPP amplitude 
f. ACh potential 
g. Carbachol potential 
h. Electrotonic potential 
METHODS 
Experimental Animals 
Ma 1 e CF! mice were obtained from the Charles River 
Breeding Laboratory. The mean weight of the animals was 39 
grams. Mice with gross organ pathologies were not used. 
The animals acclimatized for 2 weeks before they were U'ed 
for experimentation. 
same time of day. 
All of the experiments began at th•· 
Dissection of the Phrenic Nerve-Diaphragm Preparation 
A mouse was decapitated and strapped to the dissect; 
table by the limbs. The skin was incised down the ventral 
midline and separated from the abdominal and thoracic body 
wall. The pectoralis muscle groups were removed from the 
ribcage. The abdominal perineum was cut away from the 
ribcage. A midline, caudal cut was made along the 
sternum. To one side, a lateral cut was made, leaving the 
diaphragm attached to one or two ribs. The phrenic nerve 
was identified by following the nerve rostrally to the 
region of the thymus. In that region, the nerve was ligated 
and cut proximally to the site of ligation. The same 
procedure was followed on the other side of the animal. A 
dorsal cut liberated the diaphragm. With both phrenic 
nerves attached, the diaphragm was transferred into a 
chamber containing Ringer solution. There, the diaphragm 
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TABLE 0 
This table shows the composition of the perfusates used 
in the present work. 
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RINGER PERFUSATES 
Ca-1PDNENTS OF NORtW. AND K>DI FI ED RINGER - LOO<E SOLLITI ONS 
EMPLOYED IN TH IS STUDY WERE AS FOLOf.'S~ 
NORMAL RINGER 
Lo,..i C,6;++/H I GH .MG++ 
.(orf PNENIS RINGER 
NACL 136.8 M"1 136.8 M"1 
KCt. s.o M"1 s.o M"1 
CACt.2·2HiO 2.0 M"1 0.23 M"1 
M3CL.2.6HiJ 1.0 M"1 ll,0 t-11 
NAH~ 12.0 M"1 12.0 M"1 
NAHf04 1.0 W1 1.0 W1 
D-GLUCOSE 11.0 W1 11.0 W1 
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was separated into two hemistructures; and the superficia·: 
connective tissue, covering the muscle, was carafully 
dissected (Hasuo, personal communication). 
Perfusion 
After dissection, the preparation was equilibrated in 
oxygenated (95% o2, 5% co 2) Ringer-Locke solution for 15 
minutes. Following this time, the tissue was pinned into an 
experimental chamber, with a volume of approximatley 2.5 
ml. This chamber was continuously perfused at a rate of 3-
4.5 ml/min. 
perfusate was 
By warming the 
maintained at 30° 
perfusing solution, the 
C. The drug containing 
solutions and ionically altered solutions were perfused by 
the same route (Table O); a different reservior (R) was used 
in each case. Solution types were changed by opening a 
different stopcock on the perfusion regulating system 
(PRS). (for a visual description, see the overall scheme.) 
Description of the Overall Experimental Scheme 
To give the reader a general idea of the equipment 
layout, this schematic (Schematic 1) represents the whole 
recording system. The scheme can be divided into two 
portions: the top portion consists of the electronic 
equipment within the Faraday's cage. The lower portion 
mostly contains the monitoring and acquisition equipment 
outside the cage. The section within the cage, consists of 
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SCHEMATIC 1 
Combination of all the experimental methods used in the 
present work. For a detailed description, see the 
text. For a description of the equipment and 
abbreviations, see the appendix. 
SI 
S2 
s 
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a tissue bath which is perfused by oxygenated Ringer 
solutions of different composition. (see the section on the 
perfusing system). The perfusate's temperature is 
maintained by warmed water pumped through a chamber 
containing the coiled perfusate line (temperature chamber) 
The temperature is monitored by an electronic thermometer 
(ET) The center of the scheme is occupied by the tissue 
bath with a hemidiaphragm and phrenic nerve. The muscle is 
pinned to the bottom of the chamber lined with silicone 
(Elastomer by Sylgard). The nerve enters a stimulation 
chamber which is separated from the main muscle containing 
chamber by a silicone grease wall. The stimulation chamber 
contains two silver wire electrodes bathed in paraffin; the 
nerve is in contact with both wires. These two electrodes 
receive input from the stimulator, S-88, via the isolation 
unit (IU). The stimulation of the nerve is utilized in the 
EPP, EPC and CAP experiments. There are four glass 
electrodes shown in this scheme. The action potential 
recording glass electrode is shown abutting the phrenic 
nerve; the signal from that electrode is recorded by the 
differential amplifier of the oscilloscope and referenced to 
the ground electrode (CE) {for a detailed description of 
this recording, see the methods for the compound axonal 
potential). There are two electrodes inserted into the 
muscle cell: a voltage following, glass electrode (VR) and 
a current injection, glass electrode (IE). Both of these 
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electrodes are connected to the WPI-7000 mainframe. The WP! 
unit was used in all of the intracellular recordings, 
including the voltage clamp experiments. The (IE) was used 
in the voltage clamp experiments, as well as, the 
electrotonic potential experiments. The pressure ejection, 
glass electrode (PE) is the fourth electrode shown in the 
scheme. It was used in the ACh and carbachol potential 
experiments; it received pressure input from a pressure unit 
(PIU), which in turn received a command pulse of variable 
amplitude and duration from the main picospritzer module. 
The picospritzer is triggered by the S-88 stimulator. 
Monitoring and amplification of the physiologic signals for 
recording is done by oscilloscope (01). 
Outside of the cage, the system consists of a pen-
recorder (PL), used for RMP monitoring; the oscilloscope 
(02), for monitoring the physiologic signals outside the 
cage; an IBM-XT PC computer for data acquisition, storage 
and analysis; and a FM tape recorder (FM) for the storage of 
analog data. The broken lines leading from the "cage" are 
signal conducting lines and the solid line is a trigger 
signal. This pattern is followed in all the schematics. 
General description of the Recording Systems 
This electrophysiologic set-up consisted of a WPI-7000 
mainframe with individual modules (see Schematic 1). One 
module, a WPI-S7071A, was used as a current pump in the 
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voltage clamp experiments, with a probe capable of passing 
10 microampe:es. This module also facilitated the recording 
of voltage changes. ~he second module, a WPI-S7050A, was a 
voltage follower with a differential amplifier. It was used 
in voltage recording experiments as well as in voltage clamp 
experiments. In the voltage clamp experiments, this module 
was used as a voltage sensor which then commanded the 
current pump to inject the current needed to follow the 
voltage. The third module was a S-7100A control module 
which allowed the measurement of electrode resistance at the 
tip. The resistance measurement was displayed on the 
digital screen. This also facilitated the measurement of 
the RMP by means of two different probes i.e., current and 
voltage probes. Besides voltage measurements, the current 
injected into a cell was measured by means of a digital 
current follower. 
The Tektronix 5103N oscilloscope (01} was used for 
several purposes. First, it monitored the voltage change 
due to signal generation and the RMP. In compound action 
potential recording, it served as a differential amplifier. 
Finally, it served as an amplifier for the analogue plotter 
(PL}, FM tape recorder (FM} and computer input. 
Two Grass S-88 stimulators (Sl & S2} were used for 
(a) stimulation of the phrenic nerve via the isolation unit 
(IU), (b) triggering the computer, (c} triggering the 
oscilloscope, (d) pulse generation in the electrotonic 
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potential recording and (e} triggering the picospritzer. 
An electronic thermometer (ET} was used for continuous 
monitoring of the bath temperature. 
65 
COMPUTERIZED DATA ACQUISITION AND ANALYSIS 
Data Acquisition Programs 
This computerized system was IBM-XT PC based; (see 
Schematic 2) it consisted of two functional components: 1) 
an on-line acquisition system and 2) a data analysis system 
(see Schematic 2). Depending on the experiment performed, 
the on-line data acquisiton system consisted of at least two 
channels of analogue input. For example, the "GET MEPP" 
program utilized the analogue input in such a way that after 
the input was converted to a digital signal by the Tecmar 
Labtender Board (A-D), the program continuously monitored 
the average baseline. The experimenter determined the 
threshold at which a given data sample was to be considered 
an mEPP. The threshold level was used as a trigger by the 
computer. An mEPP fulfilling the threshold requirements, 
would be considered as a data sample. 
There are three evaluations performed upon this 
sample: 1) the amplitude of the sample was calculated as 
compared to the average baseline; 2) the number of events 
(mEPPs) was counted; and 3) the total waveform may have been 
saved. Each of these procedures was performed in five 
second intervals, at the end of which the data was stored 
into corresponding storage files. Each of these storage 
files was independent of the other with individually 
assigned addresses, i.e., 11 MEPPEVG.D 11 for the amplitude, 
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SCHEMATIC 2 
Data acquisition system based upon the IBM-XT PC. A,B 
& C represent inputs from the amplifier in the 
Faraday's cage. They carry trigger signals {solid 
lines), data signals {broken lines), such as the mEPP, 
EPP, EPC and DC data signals e.g., the RMP. 
These signals enter the diode box {DB) containing 
Zenner diodes. The diodes eliminate signals greater 
than + SV and prevent damage to the computer boards. 
The A to D {A-D) is a Tecmar board, serving as an 
analogue to the digital converter. Digitization of the 
signal is under data aquisition ~ontrol, which in turn 
is subordinate to the keyboard {KB) commands. Acquired 
data may be stored, analyzed and then, plotted. 
Plotting may be done on the Monitor {M) or on the 
digital printer {PR). The operation of the printer and 
the monitor are interdependent and controlled by the 
experimenter from the keyboard. The arrows leading 
from the keyboard to the interdepartmental transition 
gates represent the experimenter's control flexibility 
over the above mentioned processes. 
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"EPPCUT.P" for frequency and "MEPPAMP.O" for the whole 
waveform. Another type of input into the computer in this 
program is a DC input responsible for keeping track of the 
RMP. The RMP, in the other programs, was sampled every five 
seconds and its file (RMP.O) updated. 
Another set of programs has been written to accomodate 
a collection of evoked responses. These are EPPs, EPCs, 
pressure generated potentials, electrotonic potentials, ACh 
potentials, carbachol potentials and action potentials. All 
of these programs utilize a trigger signal which allows the 
acquisition programs to be activated, i.e., to begin 
sampling. This trigger signal was a square pulse of at 
least 2 volts in amplitude and 1 millisecond duration, 
generated by a Grass S-88. The computer responds to the 
falling phase of the square pulse as the signal to start 
sampling from the physiologic signal channel. The delay 
adjustment on the Grass S-88 al1ows the manipulation of the 
response's appearance with respect to the time window so 
that the experimenter may eliminate stimulation artifact 
from a given sample. 
There are two program types which may be used for the 
evoked response acquisition experiments: one is written in 
the computer language, BASICA and utilizes an 8 bit board; 
the other is written in APL and utilizes a 12 bit board. 
Because the BASICA programs were written first, the initial 
thesis work was done utilizing these programs. This 
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program, named EPX, was organized to collect the amplitude 
of a given waveform as compared to the baseline. This 
program provides an option that allows the investigator to 
collect the whole waveform for every specified time 
interval. The RMP was evaluated throughout the 
experiment. The interval at which the RMP was sampled was 
again, set by the investigator. The data storage was 
organized into three files with addresses: "control", 
11 drug", "washout". During the experiment, one must change 
the data-flow from the control file to the drug file to the 
washout file. 
Although the APL program (WORK2} was less complicated 
to use, it did not have the computer-analyzed RMP 
synchronized with the waveform acquisition; however, the RMP 
could be monitored by a pen-recorder or visual inspection of 
the digital output from the WPI-7000. In this program, the 
data were stored in one file; thus, the experimenter had to 
record the time of drug application, washout, etc. The 
advantage of this program was that it was very user-friendly 
and was very simple to run. 
either pre viewing data as 
automatically. One had 
Also, it geve one the option of 
it was collected or storing it 
the additional flexibility of 
analyzing the signals through a wide range of time windows, 
starting with 2.5 milliseconds/division extending through 
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minutes. The polarity of the signal was of no consequence; 
both positive and negative signals could be stored· with 
equal ease. 
Description of the Analysis Programs 
The most comprehensive analysis system was written in 
BASICA, for this language is capable of plotting, by means 
of the TIMEGRAPH program, the response amplitude over time, 
the RMP over time (TIMERMP), the average collected waveforms 
(WAVERAGE) and calculating the 50% rise-time, and the 50% 
and 75% decay-times. 
In the experiments in which the quantal content was 
measured, one of two methods was used, the failure or 
variance method, depending on the experiment (see below for 
details). In the case of the failure method, the quantal 
content could be calculated by the AMPEVOKE program. This 
program was later altered by employing a subroutine to 
calculate the quantal content by the variance method. 
The mEPP programs were written in the language 11 C11 • 
The mEPP analysis programs were as follows: the AVGFRQPLT 
program plots the mEPP frequency collected during the five 
second intervals; it plots the frequency over time. The 
AVGAMPPLT allows for a plot of the average amplitude during 
the five second intervals, over time. Finally, the 
AVGRMPPLT displays the RMP, over time. 
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The APL programs were the most easily modified for 
experimental needs, making possible the analysis of positive 
and negative peaks. When these programs were used, either a 
single or an averaged waveform could be retrieved from the 
memory. Also, the data could be sent directly to the 
statistical analysis program which could perform a paired or 
unpaired Student t-test. Like the others, i.e. BASIC or 
11 C11 , programs in this language are capable of plotting the 
amplitude over time. Here again, as in the C programs, it 
is up to the investigator to designate the times of 
different experimental phases. 
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Description of the Statistical Analysis 
The data were gathered via on-line analysis of a 
digitized signal. This signal was evaluated as to amplitude 
and waveform, 
mEPPs. This 
as well as; the frequency, as in the case of 
analysis was performed in designated time-
windows, for example, 10 minutes in the case of EPPs. 
The raw (unaveraged) data were temporarily stored in 
specifically designed bins of memory, addressed as 
"control", "drug" and "washout". Next, the data were 
transferred onto the floppy disc. From this disc, the data 
were analyzed, using programs developed in the 
experimenter's laboratory that allowed graphic 
interpretation. The flexibility provided by the graphic 
programs al lowed the experimenter to interpret of the data 
in the average-over-time format: individual plots of 
amplitude over time, frequency over time, etc. were made for 
intra- and inter-experimental analysis. 
First, we analyzed the data by comparing the control 
parameter to the PLC application parameter. Then, we 
calculated the percentage of change. These· three pieces of 
information, i.e., the average control, the average PLC 
response and the percentage of change, were then included in 
a pool of other similar experiments. Statistical analysis 
was performed upon the pooled averaged control and the 
pooled averaged PLC response. The tables summarizing these 
results contain values for the pooled averaged control and 
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PLC effect from several different experiments. For 
evaluating the null hypothesis, we used the two-tailed, 
paired, Student t-test. The percentage of change was an 
average of the pooled data. 
In a given experiment, the preliminary work allowed 
one to execute the Ruhling recommendations (Ruhling, 
1980). The Ruhling recommendations state that at the onset 
of experimentation, one should choose the alpha and beta 
values. Then, after establishing the variance from the 
previous results, one can calculate the appropriate number 
(n) of experiments. These recommendations were fol lowed 
through0ut this project. 
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GENERAL ELECTROPHYSIOLOGIC METHODS 
Microelectrodes 
WPI, glass capillary tubes of two types were used; one 
had thick walls and a small opening with an outside diameter 
of 1.2 mm and an inside diameter of 0.58 mm. The other had 
thin walls and a large opening with an outside diameter of 
1. 0 mm and and inside diameter of O. 68 mm. It was found 
that the thick-walled microelectrodes were more useful for 
intracellular recording for they would penetrate the muscle 
membrane with greater ease, leading to more stable 
recordings. 
Several methods were used to fill the microelectrode 
with 3 M KCl. Direct injection of 3 M KCl into a freshly 
pulled electrode was convenient, but frustrating: to extrude 
the bubbles, the electrode had to be tapped; this frequently 
ended in breakage (Ohta, personal communication). Since 
many electrodes had to be prepared at one time, boiling the 
electrodes in distilled water and storing them in 3 M KCl 
for equilibration proved to be time consuming (Nishimura, 
personal communication). Also, with time, boiled electrodes 
tended to become dull, leading to difficult muscle 
penetration. The most successful method, in the hands of 
this investigator, was to fill the electrode with distilled 
water via capillary action until the tip was full. The rest 
was filled with 3M KCl. Fifteen minutes of equilibration 
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was sufficient to have a sharp and bubble-free electrode. 
The microelectrodes used for pressure ejection- were 
filled with drugs by direct injection. All of the 
electrodes were pulled on a PN3 horizontal puller. 
Intracellular electrodes, used in voltage and current 
recordings, had a tip resistance between 10-30 Mohms. The 
electrodes used in the current injection had resistances 
below 10 Mohms; the pressure ejection electrodes exhibited 
1-5 Mohms of resistance. The extracellular electrodes, used 
for compound action potential recording, were made by 
pulling a high resistance electrode, (100 Moh111s) and then 
breaking the tip. To ensure a controlled breaking process, 
the microelectrode was mounted in a micromanipulator and 
advanced against a glass shield until the electrode broke, 
the goal being to achieve a square-end microelectrode. 
Then, the electrode was finely polished in the electrode 
puller; the tip size could also be adjusted by repeated 
exposure to heat. 
These methods of microelectrode preparation were 
employed in this laboratory, previously, and described in 
published papers (Schinnick-Gallagher and Jacobs, 1976; Ohta 
et al., 1981; Ohta and Karczmar, 1981). 
Localization of Endplates 
A Nikon microscope with an amplification of 80x gave 
little guidance as the density of endplates in close 
proximity to axons is quite high. 
random penetrations were performed. 
or less was used as the criterion 
positioning (Gallagher, 1972). 
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So, in that region, 
A rise-time of 1.msec 
for correct elect rode 
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Experimental Paradigm 
In each of the experiments involving intracellular 
recording, only the cells with a RMP more negative than -60 
mV were used. Before recording the actual control, a period 
of 5 minutes was used. If the cell showed instability by a 
shifting RMP, the electrode was withdrawn and a new cell was 
located. The actual, recorded, control period was 10 
minutes. The drug application time varied from 15 minutes, 
in the early phases of this work, to 3 0 min in the later 
phases. The reason for the change was twofold. First, in 
the experiments involving low Ca++/high Mg++ in the presence 
of 0.1 u/ml of PLC, the stability of the cells was limited; 
one could rarely maintain a stable recording for longer than 
20 minutes; however, this was possible in other 
experiments. Secondly, sometimes during the washout, a 
potentiation response, greater than that recorded during 
drug application, was observed; (see Results). In order to 
understand this phenomenon, the drug was applied for a 
longer length of time. 
In general, the paradigm consisted of 5-10 minutes of 
control recording, followed by 15-30 minutes of drug 
application. In some experiments, when the cell remained 
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stable, recordings were performed throughout the washout 
period. Usually, however, fasciculations were observed, 
during the washout period, leading to dislodgement or 
displacement of the electrode. 
SCHEMATIC 3 
Recording of the compound action potential. 
detailed description, see the text. 
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Recording the Compound Action Potential 
Several methods of recording the axonal a.ction 
potential (AP) were utilized. First, an attempt was made to 
record the pre-junctional action potential together with the 
extracellular EPP, using the method described by Katz and 
Miledi (1965). In this method, KCl-filled electrodes with 5 
Mohms resistance were placed at the endplate regions. The 
muscle was immobilized with 11 mM MgC1 2, and the AP with the 
EPP wave recorded. However, this method was unsuccessful in 
generating 
preparation 
any 
was 
consistent 
also 
response. 
tried, but 
A 
was 
cut-muscle 
similarly 
unsuccessful. Next, a modified version of the Randie et al. 
(1964) method was tried; in this method, wire electrodes for 
both stimulation and recording 
were positioned in different 
were used. The electrodes 
locations on the nerve and 
separated from each other by silicone grease. In between 
the stimulating and recording electrodes, a ground electrode 
was located. Muscle contraction was inhibited by 3 JJM 
dTc. Although frequently successful, this method was 
unreliable and plagued with leakage of the Ringer solution 
along the nerve into the oil chamber, resulting in a large 
artifact. 
Finally, the method of Jiang (personal communication) 
modified by the author, showed to be easy and very 
reliable. As shown in Schematic 3, the recording electrode 
included an electrode holder designed for the patch-clamp 
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technique. It consisted of an airtight electrode mounting 
w h i c h s e r v e d a s a n out 1 et t h r o u g h w h i c h s u c t i o n co u .1 d b e 
applied (IS). The electrode holder had a silver wire which 
entered into the electrode when the latter was in place. 
This wire was connected to the female portion of the 
electrode holder. On the outside of the electrode, another 
silver wire was looped 1.0 cm from the tip of the 
electrode. This wire was secured to the plastic body of the 
electrode holder so that it was electrically separate from 
the interelectrode wire. These two wires constitute the (+) 
and (-) inputs to the differential amplifier. A third wire, 
a 1 so s i 1 ver and pl aced away from the two recording wires, 
served as a common ground (CE). The recording was done by 
sucking a portion of the nerve into the 1 mm glass electrode 
tip with a diameter approximately equal to the diameter of 
the nerve. To insure that the electrode did not injure the 
nerve, the tip was fire polished. The recording was done in 
a preparation where muscle contraction was prevented by 
transversely cutting the muscle fibers, in the presence of 
low Ca++/high Mg++ and of 1-3 ~M dTc. The recording 
arrangement was as follows: the positive, negative and 
ground inputs were fed into a differential amplifier of a 
Tektronix oscilloscope, 5103N (01). This oscilloscope also 
served as an amplifier for the computer input (IBM-XT). 
After amplification, the signal from the recording electrode 
entered an A to 0 converter (Labtender by Tecmar) (A-0). 
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SCHEMATIC 4 
RMP recording by the pen-recorder (PR). The voltage 
recording electrode (VE) is positioned in the region of 
the endplate. The ground electrode (CE) is located in 
the bath. A WPI-7000 unit was used. An oscilloscope 
(01) served as a monitor and DC amplifier. 
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Then after digitization, the signal was stored in the 
computer's memory for retrieval and analysis. Nerve 
stimulation was carried out by applying a square pulse three 
times above the threshold, with a duration of .01 
milliseconds; a Grass S-88 (Sl} was used. Generation of 
this pulse was triggered by another Grass S-88 (S2} which 
simultaneously triggered the computer program to sample the 
data and initiated the oscilloscope sweep to begin. The 
second stimulator facilitated the delay adjustment in 
sampling by the computer. 
Recording the Resting Membrane Potential (RMP} 
The resting membrane potential (RMP} was recorded by 
inserting an appropriate microelectrode into the junctional 
area. The location of the electrode relative to the post-
synaptic membrane was verified by observing the mEPPs, as 
described previously. After establishing the stability of 
the cell's RMP, PLC perfusion was initiated; the concen-
trations ranged from 0.01 u/ml to 50 u/ml. The recording 
was performed by an analogue pen-recorder. Schematic 4 
shows the recording set-up. 
Recording the Miniature Endplate Potentials (mEPP} 
The mEPPs were recorded with an intracellular 
electrode positioned in the endplate region, (see the 
General Methods for a detailed description.} Since the 
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SCHEMATIC 5 
Recording set-up used in the mEPP recordings. The 
microelectrode is located in the junctional region, 
facilitating RMP 
amplified (01), 
and signal recording. After being 
the two signals enter the IBM's AD 
board; after these signals are converted to digitized 
signals, they are stored on the disc. The mEPP signal 
also is stored in its analogue form on tape by the 
Velter FM tape recorder (FM). After the experiment, 
the signal was re-played into the IBM for repeated 
analysis. Analysis of the data was performed after 
each experiment. 
• 
• • • 
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amplitude of mEPPs was generally around 1 mV and because the 
computer program used to acquire data was triggered by the 
threshold set by the investigator, it was important to have 
a recording relatively free of baseline noise. This was 
accomplished by selecting an electrode with a sharp tip and 
relatively low resistance. By doing this, it was possible 
to reduce the noise level to about 5-10% of the signal, thus 
allowing for a threshold setting at about 65% of the 
signal. In the few cases where the noise level changed 
during the experiment, the threshold could be readjusted. 
However, if there was an apparent shift in the computer-
recorded frequency and/or if the amplitude was in conflict 
with the investigator's observations, the experiment was re-
entered into the computer from the FM tape recorder, used as 
a back-up system, and the two recordings were compared. 
However, in the case of this work, only one experiment had 
to be re-evaluated. The schematic of the recording set-up 
is prepresented in Schematic 5. 
Recording the Endplate Potential (EPP) 
EPP analysis was performed in two different Ringer 
solutions. One solution contained a high Mg++ (11 mM) and a 
low Ca++ concentration (.1 mM), the other contained dTc, 1-3 
uM. The recording set-up was similar to that used in the 
Quantal Content Analysis. An acquisition program written in 
BASICA was used. The individual waveforms were collected 
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SCHEMATIC 6 
ACh potential by bath application. Immediately prior 
to ACh injection, the experimenter presses a manual 
trigger on the S-88 to initiate the recording th rough 
the voltage recording electrode (VE). The signals 
(EPPs & RMPs) are seen on the oscilloscope screen. 
After amplification, the signal travels to an A to O 
board; it is then stored on the disc and/or printed. 
The RMP is monitored by the pen-recorder and the 
digital read-out from the WPI-S7100A. 
\0 
0 
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every minute; thus, 10 waveforms were collected during the 
control period and 30 during PLC application. The rate at 
which the computer sampled the waveforms was dependent upon 
the memory available for this specific function. The 
waveforms were analyzed as to their amplitude, rise-time and 
50%, as well as, 75% decay-times. Failures occurred in the 
experiments where 1 ow Ca++/hi gh Mg++ were used. Si nee the 
computer program for the analysis of the EPP amplitudes was 
unable to eliminate these failures, a histogram program was 
written. This program's function was to plot the number of 
EPPs as related to their amplitude {histogram). This 
program also gave a qualitative and quantitative indication 
of whether or not the amplitude of the EPPs changed in the 
presence of high Mg++ and low Ca++, during PLC application. 
In a solution containing dTc, the recording of EPPs was 
carried out as described above; the only difference between 
the two experiments was that the latter did not contain 
failures. 
Recording the ACh Potential 
The evaluation of the ACh potential is useful for 
recording a post-synaptic response and evaluating endplate 
sensitivity without involving pre-synaptic structures. 
There are several ways which this response can be 
elicited. Bath-applied ACh leads-to depolarization. This 
approach was tried; but, probably due to desensitization, it 
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was found that consistent recordings were difficult to 
obtain. A modified method used 0.1 M ACh dissolved in 
Ringer solution injected directly into the bath. This 
injection was performed manually by a microliter syringe 
positioned in a given area of the bath by means of a 
micromanipulator. The positioning of the syringe did not 
change, nor did the volume injected; the only variable was 
the pressure with which ACh was ejected. Even that 
parameter became constant with practice. This method was 
found to be more successful in obtaining consistent 
responses. Ultimately, the concentration of ACh used varied 
from 0.1-0.05 M. After localization of the endplate by the 
mEPP rise-time criteria (Gallagher, 1972) and stabilization 
of the RMP, ACh was injected into the bath, starting with a 
low concentration that was gradually increased to where a 
response was recorded without generating a muscle 
contraction. Consecutive injections were separated by 10 
minute intervals of wash. Upon obtaining a set of two good, 
control recordings, PLC perfusion was initiated; another set 
of injections followed. As in the compound action potential 
recordings, the data were collected by an APL program. Just 
prior to the injection of ACh the experimenter initiated the 
recording (see Schematic 6). 
Iontophoretic application of ACh was attempted; but 
the success was minimal. It was difficult to get close 
enough to the junctional region to generate a consistent 
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SCHEMATIC 7 
Acquisiton of A Ch and carbachol 
Microejection is done by a 11 Picospritzer 
Valve Corporation, for the ejection 
pressure ejection electrode (PE). This 
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potentials. 
111 by General 
through the 
unit utilizes 
N2 as a gas source. The Picospritzer is triggered by a 
square pulse of I ms duration and 5 V amplitude 
generated by the Grass S-88 stimulator (SI); the other 
channel of the S-88 stimulator is used for the computer 
trigger. Both channels are synchonized and triggered 
by a second Grass S-88 stimulator (S2). The other 
arrangements were similar to those in bath applications 
of ACh. 
S1 
S2 
B[] 
WPI 
• 
--., 
I 
I I A-0 
potential. A 
t r i e d, as we 11 
iontophoretic 
95 
variety of ACh-containing electrodes were 
as, two different means of injection:. an 
unit and two Grass S-88s were used for 
retention and ejection currents. 
The most successful method utilized the "picospritzer" 
(pressure ejection) for microejection; it has been suggested 
that this method is more predictable than the iontophoretic 
method in terms of quantitative delivery (Woody et al., 
1979). 
The ejection electrode was pulled with a tip 
resistance of 100 Mohms. Then, control led breakage of the 
electrode tip was performed. The electrode was filled with 
0.01 M ACh. The placement of the electrode was controlled 
by a micromanipulator. As described previously, the 
endplate region was localized. Then, the ejection electrode 
was positioned in close proximity to the recording 
electrode. If due to leakage of ACh, depolarization was 
observed, the electrode was changed. The amount of pressure 
used for ejection remained constant; the ejection duration 
varied. The goal was to obtain a sizable response without 
the generation of a muscle twitch. The programs used for 
acquisition and analysis ·of the data were written in APL 
(for the recording, see Schematic 7} 
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Recording the Quantal Content 
In this thesis, two methods were used to evaluate th~ 
quantal content: the failure method a~d the variance 
method. The following is a short description of the 
theoretical background for each of these methods. 
The empirical observations were carried out by del 
Castillo and Katz (1954), leading to the quantal 
hypothesis. They demonstrated that the endplate potential 
can be reduced to a unit identical to the mEPP. This was 
accomplished by increasing the Mg++ and decreasing the Ca++ 
concentration in the perfusing solution. By analyzing the 
amplitudes of these responses, it appeared that they were 
distributed in such a way as to be described by the Poisson 
distribution expression. 
of binomial distribution. 
This expression is a special case 
In this case, although the number 
of release sites (n) is large, the probability is small tha' 
a single quantum (o) will be released. The av rage quanta 
released (m) per trial is then described by the tquation: 
m = pn 
The rule of thumb describing this relationship is: 
p .'.S... 0.05 and n > 100 
(Junge, 1981). 
The failure method of calculating quantal content is 
restricted to the conditions described above, i.e., in the 
perfusate, transmitter release has been inhibited by low 
Ca++ and high Mg++ concentrations. Where m is the mean 
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number of quanta liberated by an impulse, the probability of 
an EPP occurring with (x) quanta is given by the equation: 
Px = e-mmx/x! 
A direct method of quantal content estimate (m) may be 
represented as follows: 
m = EPP amplitude/mEPP amplitude 
With 0 quanta or failures, the probability of an EPP 
occurring can be expressed as: 
P = e-m 
By solving for m, one obtains: 
m = ln(N/No) 
This expression was described by del Castillo and Katz 
(1954). If the Poisson relationship held, then: 
m = EPP amplitude/mEPP amplitude = ln(N/No) 
The latter equation was used, in this dissertation, 
for the quantal content estimate by the failure method. 
In the experiments in which dTc was used to prevent 
muscle contraction, the variance method of quantal analysis 
was employed (Warnick et al., 1978). As in these 
experiments, it was impossible to use a direct method of 
measurement because of the EPP supression by dTc and the 
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inability of the acquisition program to perform 
simultaneously both mEPP and EPP collection. 
The variance method is based on the assumption that 
the variance of the EPP (VEPP): 
VEPP = EPP = SD2 
where: 
SD = /VE PP 
Thus, the coeficient of the variation (CV): 
CV = l\it'PP/EPP 
Then: 
CV = SD/EPP 
By definition, (see also del Castillo and Katz, 1954c) 
the quantal content of the EPP is: 
m = 1/CV 2 
(del Castillo and Katz, 1954c). 
This, of course, is an indirect method of estimation 
and is subject to more error than the direct method; 
however, by using a larger number of samples (greatE" than 
100) the estimate improves (Boyd and Martir, 1956). 
I' 
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With high amplitude EPPs, the proportionality between 
t he qua n t a l cont en t a n d t he amp l i t u de becomes l es s l. i n ea r 
(Martin, 1966). This problem can be solved in twc ways: 
The amplitude correction factor derived by Martin (1955) may 
be used or sufficient concentrations of dTc can be employed 
to prevent the mean amplitude of EPPs from surpassing 
approximately 5 mV, the point of non-linearity. The latter 
solution was employed in this work. 
In order to test the Poisson versus the binomial-type 
of distribution, one must collect mEPPs and EPPs from the 
same junction, followed by the calculation for p and n. 
This, then, will facilitate the analysis of the quantal 
distribution by the Chi square test. If the experimental 
distribution is the same as the one predicted by the 
distribution of Poisson release, then one can be confident 
of the assumption. The method for testing the binomial 
versus Poisson distributions is described by Johnson and 
Wernig (1971). Briefly, m is estimated by the equation: 
m =total number of quanta released/number of trials. 
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Where mEPPs and EPPs are recorded (low Ca++/high Mg++) for 
the binomial calculation, the probability of release can be 
determined by: 
p = 1 - ltm 
02 = the variance of a series of (N) trials. 
n = readily releasable stores and can be calculated by: 
n = m/p. 
The number of failures (no) predicted by the binomial 
distribution is: 
no = N - ( 1 - P ) n 
To calculate the number of responses in the bins of 1, 2 and 
3 quanta, etc. as predicted by binomial distribution, one 
can use: 
nx = mx _ 1[m - p(x - 1)/x(l - p)] 
where nx represents the frequency of each x value, i.e., xl, 
x2, x3, etc., during a series of trials (N). In the Poisson 
distribution, the number of failures (no) can be calculated 
by: 
n = Ne -m 
0 
while the frequency of each x value during N trials can be 
calculated: 
nx = nx - 1(m/x). 
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The choice of methods used for (m) estimation was 
based upon the need to be consistent with the methods of 
Ohta and Karczmar (1981) so that the results from the 
amphibian and mammalian preparations could be compared. In 
this dissertation, the methods used for estimating the 
quantal content depend upon the assumption implied by the 
Poisson-type distribution of neurotransmitter release at the 
neuromuscular junction under study. The transmitter release 
may be better described by the binomial distribution, in 
which case the significance of the results, although not 
exact, may be attributed to the real difference in (m) 
(Tiedt et al., 1978, Warnick et al., 1978). 
Since the phrenic nerve-diaphragm preparation is 
frequently used for electrophysiologic studies, including 
quantal content analysis, the Poisson distribution 
assumption is well accepted (see Beranek and Vyskocil, 1966; 
Banker et al., 1982). The author could not perform the 
Johnson and Werning test for binomial versus Poisson 
distribution for two reasons: It was difficult to record 
the mEPP and EPP in dTc half-block Ringer solution because 
the amplitude of the mEPPs was lost in base-line noise. 
Also, the on-line computer acquisition system was incapable 
of simutaneously recording mEPPs and EPPs. The test's 
prerequisite for estimating (m) is the simultaneous 
recording of EPPs and mEPPs. 
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SCHEMATIC 8 
Quantal Content and EPP recording. The signal 
generated by the Grass S-88 (Sl) results in a recording 
of the EPP. The EPP, together with the RMP signal, is 
amplified by the oscilloscope 5103N (01). The Tecmar A 
to D converter facilitates computer acquisition and 
analysis. The hard copy of the data is acquired by a 
dot matrix printer (PR). The S-88 (Sl) also serves as 
a trigger for the oscilloscope and computer. 
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The recording system consisted of an electrode 
inserted into the junctional area, the criteria for ·which 
have been described earlier. The perfusion of either high 
Mg++/low Ca++ or dTc was initiated. Generally, 15 minutes 
of perfusion was sufficient to prevent muscle contraction. 
If during perfusion, the electrode was dislodged due to a 
muscle twitch, the EPP waveform was used as the criterion 
for junction location in the dTc experiments. As described 
earlier, the phrenic nerve was stimulated by a square 
pulse. The waveform data and RMP data were amplified by the 
oscilloscope amplifier, Tektronix 5103N (01}, and digitized 
by a Tecmar A to D converter. BASICA programs were used for 
the acquisition and analysis of the waveforms (see Schematic 
8}. 
The failure method experiments were analyzed by a 
program which identified the total number of trials in each 
bin, i.e., "control", 11 drug 11 and "wash". Depending on the 
waveform of the signal following the trigger pulse, it was 
possible to identify either an EPP or a failure. The data 
were stored for calculation of (m} according to the formula: 
m = l n ( N/ No} 
The variance method program used a variable bin 
according to the time established by the experimenter. 
Since the control period was 10 minutes long, the data were 
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analyzed in 10 minute bins. The experimenter was interested 
in the period of peak drug effect; then, that period of time 
was used in the pooled data analysis (see the section on 
statistical analysis). The peak drug effect was identified 
by an amplitude change in the EPPs. The variance method 
data were acquired in the same way as in the failure 
experiments; the formula used form calculation was: 
m = 1/CV 2 
Recording the Carbachol Potential 
The carbachol experiments were performed by 
microejection of the drug into the junctional area. The 
ejection, recording and analysis ~ystems were the same as in 
the ACh potential experiments. The ejection electrode was 
filled with 0.2 M carbachol; after establishing a stable 
recording, the experiment was initiated. 
Recording the Electrotonic Potential 
The measurement of the post-synaptic membrane's 
passive properties was similar to that carried out by 
Gallagher et al. (1976). Two electrodes were inserted into 
the same muscle cell. Their position in relation to the 
junctional region was established by recording mEPPs from 
both electrodes on separate channels of oscilloscope (01) 
(see the overall schematic). The criteria, for acceptable 
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placement of the electrodes, were the same as those employed 
in the mEPP studies. One electrode was used to monitor 
voltage, whereas the other was used to inject current. 
Generally, as the second electrode was introduced into the 
cell, the RMP decreased by 5-15 mV. Upon establishment of 
the cell's stability, as described previously, the recording 
was initiated (Schematic 9 shows the recording set-up). 
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SCHEMATIC 9 
Electrotonic potential monitoring. Electrode (VE} is 
used for the voltage recording, whereas electrode (VI) 
is used as a current injection electrode. An S-88 (Sl} 
stimulator was used for the square pulse injection into 
the module, resulting in a linear amount of current. 
Another S-88 (S2) was used for a synchronized 
triggering of the oscilloscope and the computer. An 
APL program was used for collection and analysis of 
this data. 
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The current injected was linear with the voltage 
applied to the external input in the S-7050A module; it was 
monitored on oscilloscope (01). The second trace, the 
electrotonic potential trace, was recorded by the APL 
acquisition and analysis programs. Current tracings were 
not stored. The RMP of the eel l was monitored by the pen-
recorder. 
Voltage Clamp 
There are several electrophysiologic methods used to 
evaluate synaptic currents. These are: concentration jump 
relaxation, i.e., EPC or mEPC; voltage jump relaxation; 
noise analysis and patch-clamp single-channel recording. 
All of these techniques have their advantages and 
drawbacks. Briefly, voltage jump relaxation is based upon 
the observation that the amount of current flowing through a 
membrane depends upon the agonist concentration and the 
membrane potential. At a given constant concentration of 
agonist, when the membrane potential is decreased 
(hyperpolarized), there will be an increase in the inward 
current and in the outward currents during the decay-time. 
The net current flow will depend upon the change in the 
driving force, as well as, upon the net time during which 
the channels are open. During the voltage jump, the decay-
time is used as a measure of the mean open-channel 
lifetime. The problem with this technique is that one must 
llO 
be concerned with the concentration of the drug in the 
synaptic region; a level that is too high may complicate the 
kinetics of the channel activity, namely, opening rates may 
interfere with closing rates. Desensitization may also play 
a role. 
The noise analysis method was developed based on a 
discovery by Katz and Miledi (1970). They found that ACh 
applied to the neuromuscular junction increases the 
"noisiness" during depolarization. They ascribed this 
phenomenon to random channel activity. By recording current 
in the above situation and then subjecting it to Fourier 
analysis, one is able to plot spectral density in terms of 
the frequency. At low frequencies, the plot is flat and at 
high frequencies, it drops; at the point of the drop, the 
frequency (fc) is related to the half-life of the channels 
( T) by: 
T: 1/2 fC 
(Anderson & Stevens, 1973) 
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This analysis also provides an estimate of single channel 
conductance (Y) by using: 
Y =Var (I)/ul(V - Veq)pT 
(Anderson & Stevens, 1973) 
where: 
Var! = variance of current fluctuation about the mean. 
Ul = mean current induced by a drug at the holding 
potential V. 
V =holding potential. 
Veq = Equilibrium Potential for the drug. 
pT = the fraction of the closed channels (it increases 
with an increase in the drug concentration). 
Because it utilizes a small patch of membrane sealed 
at the tip of the recording electrode, the patch clamp 
technique allows for the recording of single channel 
activity. By filling the pipette with agonist, one can 
measure currents generated by agonist/receptor 
interaction. The duration of these currents is related to 
the lifetime of the given channel. 
112 
SCHEMATIC 10 
Voltage clamp experiments. This schematic is basically 
the same as the electrotonic potential schematic except 
for the feedback (V-clamp) amplifier and nerve 
stimulator. 
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This work employs the concentration jump relaxation 
technique, where a sudden increase in agonist concentration 
results in synaptic current flow. The duration of this 
current flow is related to the lifetime of individual 
channels. These channels will stay open for a random, 
exponentially distributed period. The rising phase of 
current represents a number of channels opening as a 
function of time. The falling or decay-phase represents the 
distribution of closing channels. The exponential time 
constant (T} is thus a representation of the mean channel, 
open-time. This hypothesis has been supported by 
independent techniques, such as, noise analysis and patch 
clamp recordings (Anderson & Stevens, 1973; and Neher & 
Steinbach, 1978). In order to avoid problems with agonist 
diffusion into the recepto-ionic channel site, the pressure 
ejection, EPC method was used. 
Two modules of the WPI-7000 mainframe were used for 
the voltage clamp experiment (see Schematic 10). The S-
7050A ~odule was used as a voltage monitor; its function was 
to sense the intracellular potential and compare it with the 
command provided. For example, when an EPP was generated by 
stimulation of the phrenic nerve, the change in voltar;e was 
sensed and applied to the negative feedback am~l, fier. 
Amplified, this difference was applied to the secono r.Jdule 
S-7071A which served as a current pump. The curr~nt was 
measured and recorded. In these experiments, the ce11 '\ RMP 
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was held at -65 mV. The impaling technique was the same as 
described previously with regard to the methods employed in 
recording the electrotonic potential methods. After the 
stability of the cell was established, the clamp circuit was 
activated and the negative feedback was increased to the 
point where the EPP voltage was reduced to 80-90% of its 
control value. The negative feedback was increased as far 
as possible without provoking oscillation. The speed of the 
current response was also adjusted. This was done by means 
of the negative capacity adjustment; this adjustment was 
made judiciously to obtain as fast a response as possible 
without producing ringing (Linder & Quastel, 1977). The 
acquisiton and analysis data programs were written in APL. 
RESULTS 
Compound Action Potential 
The purpose of these experiments was to analyze the 
effect of PLC upon the axonal action potential as expressed 
through the measurement of the compound action potential. 
It is assumed that in the event that PLC alters the axonal 
conduction, there will be a change significant enough to be 
observed via the compound action potential. The compound 
action potential was measured in a variety of preparations. 
In these preparations muscle contraction was blocked by (1) 
the cut-muscle method (Barstad & Lilleheil, 1968), (2) dTc 
half-block and (3) magnesium block. The experimenter's aim 
in using these three approaches was to eliminate the 
possible differential PLC effect by employing varied 
experimental conditions. Figure 1 shows a typical compound 
action potential. The first plate (A} shows a compound 
action potential (CAP) with an observable muscle twitch. 
The second plate (B} shows a CAP when exposed to dTc, 3.0 
uM. This is followed in (C), by the application of 
tetrodotoxin (TTX}, 20 nM. Total inhibition of the CAP by 
TTX is seen. As would be predicted, the CAP was sensitive 
to the stimulation intensity; but, there was no great 
variation in its amplitude when the intensity was varied 
from the threshold level to three times that level. 
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;n terms of its axonal type. In the preparations of cut-
muscle, curarized muscle, and Mg++ blocked muscle,. the 
application of PLC (.1 u/ml} did not show any significant 
effect upon the CAP. The washout phase of these experiments 
was also unaltered, as shown in Figures 2, 3 and 4. 
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FIGURE 1 
Recording of the compound action potential. 
A Control recording with the muscle twitch 
present. 
B - Recording of the same potential with 3 uM dTc. 
C - Recording after perfusion with 20 nM TTX. 
A c 
lmvL 
2.Smsec 
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FIGURE 2 
Recording of the compound action potential in the cut-
muscle preparation. 
A - Control recording. 
B Recording at the end of the .1 u/ml PLC 
perfusion period (30 minutes). 
C - Recording at the end of the washout period (30 
minutes). 
A B c 
lmvL 
2.5msec 
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FIGURE 3 
Recording of the compound action potential in the dTc 
half-blocked (3 uM) preparation. 
A - Recording of the control period. 
B Recording at the end of PLC .I u/ml 
application period (30 minutes). 
C - Recording at the end of the washout period (30 
minutes). 
A B 
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FIGURE 4 
Recording of the compound action potential in the 
altered Ringer solution (low Ca++/high Mg++). 
A - Recording during the control period. 
B - Recording at the end of PLC application ( 30 
minutes). 
C - Recording at the end of the washout period (30 
minutes). 
lmYL 
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These experiments, demonstrate that PLC in 
concentrations of .1 u/ml (which proved effective in 
creating an action on neuromyal transmission; see below) has 
no effect upon the amplitude or configuration of the CAP. 
These data are in agreement with those of Rosenberg {1970), 
who found that despite releasing from 85-100% of 
phosphorylated bases, by means of 40-50 u/ml of PLC from 
Clostridium welchii, there was no effect upon axonal 
function. 
The figures also show that 
does not appear to be changed. 
the conduction velocity 
However, the greater the 
resolution in time, the more apparent the difference might 
become. Unfortunately, this recording system was unable to 
facilitate that analysis. 
Resting Membrane Potential (RMP) 
PLC was used in different concentrations, ranging from 0.01 
u/ml to 50 u/ml, to establish its effect upon the RMP 
{Figure 5). 
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FIGURE 5 
Analogue plots of the RMP in different concentrations 
of PLC. The arrows indicate the onset of perfusion 
with PLC. 
A - Tracing of the RMP where 50 u/ml of PLC was 
applied. One observes depolarization followed by 
the loss of the cell (n = 4). 
B - Tracing of the RMP where 25 u/ml of PLC was 
applied. Depolarization is observed followed by 
the loss of the cell (n = 3}. 
C - Tracing of the RMP where 10 u/ml of PLC was 
applied. Depolarization did not result in the 
loss of the cell (n = 3) for the duration of the 
experiment. 
D - Recording of the RMP where 5 u/ml of PLC was 
applied (n = 3). 
E - Recording of the RMP where 1 u/ml of PLC was 
applied (n = 3). There is some depolarizarion. 
F RMP recording where 0.1 u/ml of PLC was 
used. No apparent depolarization was observed 
(n = 3). 
r 12a 
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It was important to find a concentration of PLC which 
would exert a minimal effect on the RMP and yet have an 
effect upon synaptic events, e.g., the mEPP frequency. 
Since the goal of this study was to evaluate synaptic 
events, it was important to eliminate as many variables as 
possible; thus, the investigator's concern with RMP 
instability resulting from drug application. It was found 
that 0.01 to 0.1 u/ml concentrations of PLC had a minimal 
effect upon the RMP. However, concentrations below 0.1 u/ml 
showed no significant change upon other parameters, such as 
the mEPP frequency in the 30 minute drug application period 
(see below). The 0.1 u/ml concentration was potent in its 
effect upon synaptic events and yet did not significantly 
change the RMP during the PLC application period. 
Therefore, this concentration was used in all of the 
experiments. It should be pointed out that after boiling 
the PLC for 10 minutes, the PLC was deactivated and its 
effect upon the RMP at concentrations of 25 u/ml, abolished. 
Miniature Endplate Potential (mEPP) 
Three sets of data were collected in these experi-
ments: the mEPP frequency, the mEPP amplitude and the 
RMP. From the combined results, it appears that a change in 
the mEPP frequency and amplitude could occur without a 
significant shift in the RMP. The most pronounced effect 
was an increase in the mEPP frequency. Table #1 shows the 
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averaged mEPP frequency during the control period compared 
to the period of peak drug effect; the release of vesicles 
was potentiated by a statistically significant 60% increase 
in the frequency above the control level. 
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TABLE 1 
The table shows the results of the averaged mEPP 
frequency/5 secs. + SE and mEPP amplitude..:!:.. SE, during 
the control and drug phases. The percentage of change 
from the control is also shown. p < 0.05, indicated by 
an asterisk. n = 9. 
CONTROL 
mEPP 
frequency/Ssec 4.80 ± 
mEPP 
amplitude 1.32 ± 
<mV> 
n=9 
PLC-TREATED 
0.3 8.10 ± 1.s * 
0.11 1.45 ± 0.13 * 
Y. 
+64 
+12 
..... 
w 
N 
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FIGURE 6 
mEPP experiment. 
A - Frequency graph of mEPPs/5 seconds. 
B - Amplitude graph of mEPPs. 
c 
-
RMP graph; the arrows indicate the onset of 
PLC ( • 1 u/ml) perfusion and the beginning of 
washout. Note the inverse relationship between 
the frequency and the amplitude. 
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FIGURE 7 
mEPP experiment. 
A - Frequency graph of mEPPs/5 seconds. 
B - Amplitude graph. 
C - RMP; the arrows indicate the onset of PLC (O.l 
u/ml) application and the beginning of the 
washout. Note the potentiating effect of the 
washout. 
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Figure 6 shows an example of a typical experiment. The top 
plate (A) is a graph of the mEPPs average freqtiency 
collected in five second intervals for the duration of the 
experiment. Each horizontal bar represents the average 
frequency of mEPPs per 108 seconds. The arrows indicate the 
onset of drug application and the onset of the washout 
phase. The effect of PLC upon the mEPP frequency was clear 
cut; though statistically significant, the effect of PLC 
upon the amplitude was less extensive amounting to 10% as 
shown in Table 1. 
The second plate (B) represents a plot of amplitudes 
collected in five second intervals over time. The 
horizontal bJrs represent the average amplitude during 108 
seconds. Finally, the third plate (C) represents the 
recc:rding of the RMP over time. From these figures, it 
appears that PLC's most significant effect is upon the 
frequency of mEPPs. The amplitude appears to be less 
affected. Moreover, there appears to be an inverse 
relationship between the amplitude and the frequency of the 
mEPPs during the maximal PLC-induced in~rease in mEPP 
frequency. 
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TABLE 2 
This table shows the pooled EPP amplitudes in (mV) 
during the phases of the control and peak drug effect, 
as well as, the percentage of change from the control, 
as calculated for each experiment. During the control 
and peak drug effect, the amplitude, the 50% rise-time 
in (ms) and the 50% and 75% decay-times were calculated 
for these experiments with the percentage of change 
calculated. p < 0.05. Statistically significant 
results are indicated by an asterisk. 
n = 9. 
CONTROL PLC-TREATED x 
EPP 
APLITUDE 1.6 ± 0.26 2.0 ± 0.34 * +24 
<mV> 
50X 
RISE-TIME 0.43 ± 0.08 0.49 ± 0.1 
<mS> 
50X 
DECAY-TIME 1.1 ± 0.06 1. 3 ± 0.1 
* 
+21 
<mS> 
75X 
DECAY-TIME 2.1 ± 0.1 2.6 ± 0.2 * +24 
· <mS> 
n=9 
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FIGURE 8 
EPP experiment performed in half-block (1-3 uM) dTc. 
A - Plot of the averaged amplitudes. 
B - RMP during the experiment with the arrows 
indicating the onset of (0.1 u/ml) PLC 
application. 
C - Actual averaged w2veforms collected during the 
control period. The 50% and 75% decay-times and 
the 50% rise-times are also shown. 
D - Actual averaged waveform collected at the end 
of the drug application period. 
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TABLE 3 
This table shows the results of the EPP's amplitude 
(mV), rise-time and decay-time (ms) analysis in low 
Ca++/high Mg Ringer. The averaged 50% and 75% decay-
times + SE are shown during the control and drug 
periods, as is the percentage of change as compared to 
the control. p < 0.05, indicated by an asterisk. n = 
9. 
CONTROL PLC-TREATED 
EPP 
AMPLITUDE 2.3 ± 0.4 3.0 ± 0.5 • +41 
<mV> 
50X 
RISE-TIME 0.43 ± 0.02 0.42 ± 0.01 
<mS) 
:50X 
DECAY-TIME 0.88 ± 0.1 1.10 ± 0.1 • +28 <mS> 
75X 
DECAY-TIME 1.60 ± 0.15 2.10 ± 0.27 * +31 
<ms> 
n=9 
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Figure 7 shows another experiment in which an 
interesting phenomenon was observed, i.e., a biphasic effect 
of PLC on the mEPP frequency. In plate (A) a primary 
potentiation of the mEPP frequency can be seen followed by 
an even greater enhancement during the washout phase. 
Observations of this type, led the investigator to extend 
the duration of PLC application. Plate (B) shows the 
correlation of the mEPP frequency and the amplitude during 
the frequency changes. As observed in the previous figure 
(Figure 6), there seems to be an inverse relationship 
between the frequency of mEPPs and the amplitude. Plate C 
shows that there was no change in the RMP. 
Endplate Potential (EPP) 
In Table 2, the pooled data concerns EPP amplitudes, 
recorded in a dTc Ringer. They indicate a statistically 
significant mean 24% increase in the amplitude due to the 
action of PLC (n = 9). As it may be seen in the Figure 8, 
there is a progressive increase in the EPP amplitude after 
initiation of PLC application (Plate A). There is also a 
statistically significant prolongation of the EPPs (see 
Table 2). The two measurements were carried out with 
respect to the decay-time, as visual inspection of the 
actual waveforms indicates the appearence of a "prolonged 
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tail". To test whether the later portion of the decay 
decreased at a slower rate, the 75% decay-time was also 
measured. It appeared that PLC caused a 21% increase in the 
mean 50% decay-time and 24% increase in the mean 75% decay-
time. The rise-times showed no change. 
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FIGURE 9 
EPP amplitude experiment in the modified Ringer (low 
Ca++/high Mg++) solution. 
A - Amplitudes collected during the experiment; 
the failures are indicated as (O mV). 
B - Averaged RMP during the experiment with the 
arrows indicating the onset of (0.1 u/ml) PLC 
perfusion and the onset of washout. 
C - Amplitude histogram during the control period. 
D - Amp 1 it u de hi st o gram du r i n g drug a pp 1 i cat i on , 
indicating a shift in the EPP amplitude. 
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A typical example of PLC's action on the waveform is 
shown in Figure 8. Plate (C) shows an EPP waveform composed 
of individual EPPs during the control period, the drug 
period (D), the 50% rise-time, as well as, the 50% and 75% 
decay-times are indicated. 
In high Mg++/low Ca++ solution, the evaluation of the 
EPPs was performed (see Table 3); the averaged amplitude of 
the EPPs sho~s a significant increase, 41% above the control 
level. As compared to the control, the 50% and 75% decay-
times were prolonged by 28% and 31%, respectively; there was 
no change in the rise-time. A typical experiment is shown 
in Figure 9. Plate (A) represents a plot of individual EPP 
amplitudes for the duration of the experiment. By visual 
inspection, with time, one observes a shift in the EPP 
amplitudes together with a reduction in the number of 
failures. The bottom plates show a histogram analysis of 
the amplitudes. The top histogram (C) shows the 
distribution of amplitudes in the control phase of the 
experiment; the bottom histogram (D) shows the amplitude 
distribution during PLC application. With the appearance of 
large EPPs in the 9 mV range, it is apparent that PLC 
induced a shift in ampl~tude. 
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TABLE 4 
This table shows the results of two methods used in 
generating the ACh potential i.e., bath-applied and 
microejected. The averaged amplitudes (mV) + SE and 
the percentage of change from the mean are shown for 
both the control and drug phases. p ~ 0.05, indicated 
by an asterisk. nl = 6, the number of experiments in 
the bath applied ACh potential experiments. n2 = 4, 
the number of experiments in the microejection ACh 
potential experiments. 
CONTROL 
BATH APPLIED 
ACh AMPLITUDE 3.6 ± 0.69 
<mV> 
n•6 
MICROEJECTION 
ACh AMPLITUDE 3.8 ± 1.8 
<mV> 
n•4 
PLC-TREATED 
5.7 ± 0.60 
6.7 ± 2.4 • 
;:, 
• +59 
+82 
..... 
V1 
0 
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ACh Potential 
Both bath-applied and pressure-ejected ACh potential 
experiments show consistent results; they both indicate an 
increase in the ACh potential during PLC application. Table 
4 shows the grouped data for both types of experiments; in 
bath-applied ACh experiments, the mean amplitude increased 
from 3.6 mV to 5.7 mV (approximately a 60% increase); this 
change was significant. In the case of the pressure-applied 
ACh experiments, the increase was from 3.8 mV to 6.7 mV, an 
82% increase. This change was also significant. An example 
of each type of experiment is shown in Figures 10 and 11. 
Figure 10 shows two control recordings, plates (A) and (B), 
separated from each other by 10 minute washout periods. The 
second set of waveforms, shown in plates (C) and (D), were 
generated during P~C application; the first waveform (Plate 
C) was generated by applying ACh after 10 minutes of PLC 
application; approximately a threefold increase in size 
occurred. The last figure in the series, plate (D), shows 
the affect of ACh application after 20 minutes of exposure 
to PLC. Compared to the previous response, this response is 
potentiated still more; however, the depolarization did not 
return to the baseline. This particular phenomenon, where 
the RMP remained depolarized, was frequent in bath-applied 
ACh experiments, particularly during the second half (20 
minutes) of PLC application. 
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FIGURE 10 
Bath-applied ACh experiment. 
A - ACh potential during the control phase. 
B - Control trace 10 minutes following A. 
C ACh potentjal after 10 minutes of PLC 
application. 
D ACh potential after 20 minutes of PLC 
application. This recording did no: return to the 
control RMP. 
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FIGURE 11 
Pressure generated ACh potential. The circles indicate 
the individual amplitudes of ACh potentials. 
A - Control period. 
B - PLC (O.l u/ml) application period. 
C - Washout period. 
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FIGURE 12 
Averaged waveforms recorded during the individual 
experimental periods in Figure 11. 
a) Control period. 
b) PLC application period. 
c) Washout period. 
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A typica1 experiment with pressure-applied ACh is 
shown in Figure 11. The first plate (A) shows the 
individual amplitudes of the ACh potential during the 
control phase. The second plate (B) shows the amplitudes of 
individual ACh potentials recorded during the PLC phase. 
During PLC application, the examination of individual 
waveforms revealed no change other than a change in 
amplitude. It is interesting to observe the early increase 
in amplitude variability following PLC application. It is 
also interesting to observe the stability of the response 
towards the end of PLC application and during washout. 
The actual waveforms of the averaged responses 
obtained during the control period, the last phase of the 
drug period and the washout period, are represented in 
Figure 12. There was a marked potentiation of amplitude 
from the control level (2.8 mV), to the lev~l recorded 
during drug treatmer,t (9.2 mV), and to the level recorded 
during the washout (10.9 mV). 
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Carbachol Potential 
In view of the results observed with the ACh 
potential, to eliminate the possibility that PLC potentiated 
the ACh amplitude due to acetylcholinesterase (AChE) 
inhibition, the carbachol potential experiments were 
conducted, as carbachol is not hydrolyzed by AChE. Table 5 
shows the data pooled from 5 experiments; the mean control 
amplitude was 2.9 mV and the amplitude recorded during peak 
drug effect was 4.9 mV, an increase of 69%. The mean 50% 
decay-time for the two phases is also indicated. The mean 
control decay-time was 0.14 seconds compared to the mean 
drug decay-time of 0.18 seconds. Figure 13 shows a typical 
experiment. There are three plates, showing individual 
amplitudes over the duration of each given experimental 
phase. The first plate (A) represents the control phase; 
the mean amplitude amounted to 1.76 mV. Plate (B) shows the 
drug application phase; at the end of the drug application 
period, the mean amplitude was 3.76 mV. Finally, plate (C} 
shows the washout phase with a mean amplitude of 4.5 mV. 
The actual waveforms are shown in Figure 14. The 
three averaged waveforms are shown superimposed upon each 
other. A significant potentiation of amplitude can be 
observed between the control, drug and washout phases. 
TABLE 5 
This table shows 
carbachol potential 
the 
in 
averaged 
(mV} and 
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amplitude of the 
the 50% decay-times 
generated by microejection, during the control and drug 
periods + SE. The percentage of change from the 
control is also indicated. p ~ 0.5. n = 5. 
CONTROL 
111CROEJECTION 
CARB. Al1PLITUDE 2.9 :!: 0.82 
(mV> 
SOX 
DECAV-Tll1E 0.14 :!: 0.01 
(8) 
n•S 
PLC-TREATED 
4.96 :!: 1.4 • 
0.18 :!: 0.01 * 
x 
+69 
+33 
.... 
°' .... 
FIGURE 13 
Pressure generated carbachol potential. 
represents an individual amplitude. 
A - Control period. 
B - (O.l u/ml) PLC application period. 
C - Washout period. 
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FIGURE 14 
Averaged waveforms collected during the periods 
indicated in Figure 13. 
a) Control period. 
b) PLC application period. 
c) Washout period. 
c 
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Quantal Content 
Two methods for estimating the Quantal Content· (m) 
were used: 
In the failure method, muscle contraction was 
prevented by using Ringer solution that contained 11 mM Mg++ 
and .1 mM Ca++. This modified Ringer solution allowed a 
decreased release of ACh; occasionally, the endplate failed 
to respond to the axonal action potential. It was found 
that 0.1 u/ml PLC increased the (m} value by 32% (see Table 
6}; this change was highly significant. The table shows the 
mean quantal content of nine experiments in both control and 
drug phases. The (m) was calculated according to the 
formula: 
m = ln (N/No) 
Where N is the total number of trials and No is the total 
number of failures. 
An example of a typical experiment is shown in Figure 
15. The top plate (A) shows a plot of EPP amplitudes 
recorded throughout the experiment. Each circle represents 
a specific EPP amplitude. The failures are represented by 0 
mV amplitudes. The arrows indicate the time of PLC 
application and the washout period. Visual inspection 
indicates that there was a decreased number of failures 
during drug application and an increase in the amplitude of 
the EPPs (see the section on EPPs). The lower plate (B) 
represents the RMP values (mV) recorded for the duration of 
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the experiment; the arrows indicate the time of drug (PLC) 
perfusion and the time of washout initiation. tt is 
apparent from the figure that during the experiment, there 
was very little change in the cell's stability, as indicated 
by the RMP (Plate B). Each circle, here, represents a mean 
RMP over a one minute interval. 
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TABLE 6 
The quantal content was (m) calculated by two 
methods: the normal Ringer/variance method and the low 
Ca++/high Mg++/failure method. The Quantal Content (m) 
was calculated during the control and drug application 
periods; the percentage of change from the control is 
indicated. Each m ...:!:.. SE represents the averaged results 
of n = 9 experiments for the normal Ringer; n = 8 for 
low Ca++/high Mg++. p ~ 0.05, and is indicated by an 
asterisk. 
CONTROL PLC-TREATED x QUANTAL QUANTAL 
CONTENT CONTENT 
NORMAL 
RINGER m • 65 ± 11 m = 79 ± 12 * +23 
n•9 
I LOW Ca++/HIGH Mg++ 
RINGER m • 1.8 ± 0.3 m = 2.3 ± 0.3 * +32 
n•9 
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FIGURE 15 
Quantal content experiment where the failure method was 
used. 
A Amplitudes with c ire le s representing 
individual EPPs. 
B RMP during the experiment. Each circle 
represents the RMP during one minute. The arrows 
indicate the initiation of the {0.1 u/ml) PLC 
application and the washout period. 
C - Averaged EPP waveform (without failures). The 
EPP rise-time and decay-times are indicated. 
D Averaged EPP waveform (without failures) 
coll ec~ 2d d•:ri ng the end of the drug ap~'l i cation 
period. 
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Examples of the actual EPP waveforms are represented 
in Figure 15. Plate (C) shows a typical waveform collected 
at the end of the control period. Plate (0) shows a typical 
waveform recorded at the end of PLC application. An 
increase in the amplitude and an increase in the duration of 
the decay-phase was observed. 
The other method employed to evaluate the quantal 
content (m) was that of del Castillo and Katz (1954) as 
modified by Warnick et al. (1978). The formula used for the 
estimation of (m) was: 
m = 11cv2 
where CV is the coefficient of variation. 
As with the results obtained in the failure method 
(see Table 6), from the control period to the drug period, 
there was an 23% increase in the quantal content (m). This 
increase was significant. Here again, data are pooled from 
nine independent experiments. (For a typical experiment see 
Figure 8.) 
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TABLE 7 
This table shows the results of the electrotonic 
potential experiments, the mean amplitude (mV) .±..SE and 
the mean membrane resistance (Kohms) .±..SE, during the 
control and drug phases. The control and drug phases 
do not differ from each other. p ~ 0.05. n = 6. 
AMPLITUDE 
<mV> 
MEMBRANE 
RESISTANCE 
<kOHM> 
CONTROL 
4.9 ± 0.59 
3.7 ± 0.41 
n=6 
PLC-TREATED 
4.B ± 0.54 
3.6 ± 0.50 
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FIGURE 16 
Electrotonic potential with circles representing 
individual waveform amplitudes. 
A - Control period. 
B - PLC application period (O.l u/ml). 
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FIGURE 17 
Averaged electrotonic waveform from the control and the 
end of the drug period. 
a) Control period. 
b) Washout period. 
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Electrotonic Potential 
The study of the electrotonic potential was empl.oyed 
to eliminate the possibility that PLC's action upon post-
synaptic membranes resulting from a change in the membrane 
resistance. The recording of the electrotonic potential, 
during PLC perfusion, showed no significant change in either 
the electrotonic potential or the membrane time constant. 
Tab'e 7 shows the pooled data for the electrotonic 
potential, the peak-negative amplitude during the control 
and drug phases, as well as, the calculated input 
resistance. During drug application, the peak amplitude of 
the potential and the input resistance were unchanged. 
Figure 16 is an example of a typical experiment where 
the individual amplitudes of electrotonic potentials are 
shown plotted over the duration of the experiment. The top 
plate (A) shows the control portion of the experiment 
followed by (B) PLC application. 
The actual waveforms recorded are shown in Figure 17, 
where the averaged waveforms of the control period and drug 
period are superimposed upon each other. There was no 
significant change in the appearance of the waveforms. 
Voltage Clamp 
In the voltage clamp studies, the amplitude and the 
evoked waveform decay were analyzed via computer programs 
similar to those utilized in the evaluation of the EPPs. 
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However, in the voltage clamp studies, the voltage clamp 
circuit was used to maintain a very stable RMP and to r~cord 
the current responsible for the EPPs (see Methods). In 
Table 8, the pooled current amplitudes, during the control 
and the peak drug periods, are shown to have a net increase 
of 12%. The other information in the table includes a 283 
increase in the averaged 50% decay-time of the EPCs. 
A typical experiment is shown in Figure 18, where the 
amplitudes of individual EPCs are plotted against time. The 
top plate (A) is the control period. This is followed by 
the PLC application period fB}. The last two plates 
illustrate the events of the washout periods. It can be 
seen that there is a strong trend towards an increase in thP 
current amp!itude, especially in the washout period (Plate 
C}. Plate (D} shows further increase in the amplitude 
followed by a loss of the clamp. 
The ac .. ;.ial averaged waveforms can be seen in Figure 
19; the waveforms illustrate superimposed averaged EPCs. It 
can be seen that there is a gradual increase in the 
amplitude of the EPCs during the various experimental 
phases. The first amplitude representing a marked increase 
over the control period, is seen at the end of drug 
application; the next marked increase is seen at the end of 
the washout phase; the largest being seen during the late 
washout phase just prior to the loss of clamp integrity. 
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TABLE 8 
This table shows the results of the voltage clamp 
experiments. The averaged amplitudes are shown in (nA) 
..!_SE during the control and drug phases. Also, the 50% 
decay-times were calculated during the two phases. The 
percentage of change from the control is shown. p 
0.05, indicated by an asterisk. n = 5. 
AMPLITUDE 
<nA> 
50X 
DECAY 
<mS> 
CONTROL 
B.7 ± 1.:5 
7.8 ± 1.7 
n=S 
PLC-TREATED 
9.9 ± 1.9 • 
9.6 ± 1.6 * 
+12 
+29 
..... 
00 
N 
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FIGURE 18 
Voltage clamp experiment. 
individual current amplitudes. 
The circles represe~t 
A - Control period. 
B - PLC (0.1 u/ml) application period. 
C - Washout period. 
D - Continued washout, ending with a loss of the 
clamp. 
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FIGURE 19 
Averaged waveforms from the experiment in Figure 18. 
a) Control period. 
b) PLC application period. 
c) Washout period. 
d) Continued washout period. 
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Since potentiation during washout was a recurring 
phenomenon (see the results concerning mEPP frequency and 
amplitude), it was interesting to see if a long PLC 
application period, would result in similar potentiation. 
Figure 20 shows a typical experiment in which the washout 
phase was substituted for prolonged PLC application. 
The top plate (A) shows a control period followed by two 
plates representing PLC application periods, (B) and (C). 
As we can 
amplitude 
see, there was the typical increase in the EPC 
during the early PLC application period (B). 
Plate (C) shows the continuation of PLC application, ending 
with a loss of the eel l 1s membrane integrity. The average 
waveforms obtained in this experiment, are shown in Figure .. 
21 These waveforms are averaged during the control period, 
at the end of first drug application and during thP. 
prolonged PLC application, just prior to the loss of the 
cell's membrane integrity. It is apparent that there is a 
potentiating effect in the presence of PLC; however, it does 
not appear to be as great as during the washout potentiation 
period. The statistical significance of this difference was 
not established, for the primary objective of this study was 
not a comparison between the washout-induced potentiation of 
PLC application and the prolonged PLC application. However, 
in the future, it would be interesting to analyze the 
difference between the potentiation due to washout and the 
potentiation due to prolonged PLC application. 
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FIGURE 20 
Voltage clamp experiment. The circles represent 
individual current amplitudes. 
A - Control period. 
B - PLC (0.1 u/ml) application period. ~ 
C Prolonged PLC application, ending with the 
loss of the cell. 
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FIGURE 21 
Averaged waveforms from the periods in Figure 20. 
a} Control period. 
b} PLC application period. 
c} Continued PLC application period. 
5nA 
2 .5 msec 
...... 
\0 
...... 
192 
Summary of Results 
1 The resting membrane potential was depolarized by 
applying 50-1 u/ml PLC. This effect was time dependent 
with higher concentrations depolarizing the membrane 
sooner. A concentration of 0.1 u/ml was found to be the 
most effective in generating a synpatic response without 
a depolarizing effect. The rest of the experiments were 
performed with 0.1 u/ml PLC. 
2 In the cut-muscle preparation, the dTc-blocked 
preparation and the low Ca++/high Mg++ solution, the 
recorded compound action potential was not affected hy 
PLC. 
3 The miniature endplate potentials were P.nhanced hy 
PLC. Their amplitude increased significantly, by 12%; 
the frequency was increased significantly, by 643. 
4 The quantal content by the failure and variance methods 
showed a significant increase in the presence of PLC. A 
23% increase was seen in the normal Ringer solution and 
32% in the low Ca++/high Mg++ solution. 
5 Acetylcholine depolarization by bath-application was 
enhanced significantly, 59%, in the presence of PLC. 
The pressure ejected ACh potential was also increaser:! 
significantly, by 82%. 
6 The carbachol potential generated by microejection was 
significantly increased above the control, 69%, by the 
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action of PLC. The wave analysis of this waveform 
showed a significant 33% increase in the 50% decay-time. 
7 In the electrotonic analysis studies, neither the 
potential amplitude, nor the memhrane input resistancP. 
showed any significant change in the presence of PLC. 
8 The endplate current analysis showed a significant 12% 
increase in the amplitude and a 28% increase in the 50% 
decay-time due to the action of PLC. 
9 The endplate potentials analyzed in PLC and normal 
Ringer, and in PLC and low Ca++/high Mg++ Ringer, showed 
a significant increase in the amplitude, 243 and 41% 
respectively. The waveform analysis, under the above 
circumstances, showed a significant increase in the 50% 
decay-time, 21% and 28% respectively. and 75% decay-
time, 24% and 31% respectively. 
... 
DISCUSSION 
The discussion is organized chronologically to follow 
the physiologic events at the neuromyal junction, i.e., the 
pre-synaptic effects of PLC will be discussed first, 
followed by the postsynaptic effects. 
Compound Axonal Action Potential 
As was discussed in the introduction, axons are 
apparently very resistant systems. They are able to 
maintain conduction during insults, such as Diphtheria toxin 
demyelination or extensive dephospholipidation by 
phospholipases. The mechanisms involved are not well 
understood; yet, they may be related to the i nsul t-i nduced 
fluidity change of the axonal membrane that al lows for the 
reorganization of the Na+ and K+ channels. This" 
reorganization shows significant adaptability as it allows 
for a shift from the saltatory to non-saltatory conduction. 
In phosphol i pase studies using PLC from Cl ost ri di um 
welchii, PLO from cabbage and PLA from Ringhals venom, 
Rosenberg et al., (1968), found that axons exposed to 
con cent rations of PLC as high as 90 u/ml for 30 mi nut es, 
showed no effect upon the axonal action potential. PLO was 
also ineffective in interfering with axonal conduction. The 
PLA effect, resulting in an irreversible conduction block, 
was attributed to the toxic action of the lysophosphatides 
and free fatty acids. 
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The above results appear to be consistent with the 
observations of the present work. It was shown ·that 
exposing the phrenic nerve to PLC, from Clostridium welchii 
at concentrations of 0.1 u/ml for 30 minutes, dirl not 
produce any significant change in the amplitude or waveform 
characteristics of the compound action potential. It is 
possible that the treatment used in this work was not severe 
enough to generate electrophysiologically observable 
changes; it appears that there is a relatively high 
threshold of resistance to change. 
Considering the focus of this study, synaptic 
transmission, it might have been more useful to investigate 
pre-junctional currents, resulting from the action 
potential's invasion of the axon terminal. Bri gant and 
Mallart (1982) have shown that there are three distinct 
types of currents present in the region of the axon 
terminal. These three currents were identified by their 
location and pharmacology. Na+ currents were found to be 
localized specifically in the pre-terminal region, implying 
that Na+ channels involved in action potential generation 
are localized there; the current was blocked by TTX. K+ 
channels were located at the terminal parts of the axonal 
ending. This particular K+ current was blocked by TEA and 
aminopyridines. Ca++ currents were unmasked by K+ channel 
blockers; they were located in close proximity to K+ 
channels. It would be of great interest to analyze the 
.. 
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effects of PLC action upon these individual currents, 
especially in light of studies by Ohta and Karczmar ("1981) 
that suggest a pre-synaptic increase in Ca++ influx. 
Unfortunately, because of the anatomy of the preparation, 
this dissertation work did not lend itself to this type of 
analysis. The phrenic nerve-diaphragm preparation of the 
mouse is composed of very tightly organized muscle with 
axonal terminals visually impossible to identify. 
Fu rt he r m·o re , w i t h an ext race l l u l a r el e ct rode , a cc e s s t o 
these terminals is practically impossible because of the 
tough, connective tissue barrier. A much better preparation 
for th i s type of i n vest i g at i on wo u l d be the i n tr at ho r a c i c 
muscle, the triangularis sterni, used by Brigant et al. 
(1982). This muscle is ideal for electrophysiologic work on 
the nerve terminal; however, its dissection tends to be 
rather difficult (McArdle et al., 1981). 
Miniature Endplate Potential (mEPP) 
The increase in the mEPP amplitude, observed in this 
study, may have two components: a pre-synaptic, PLC-induced 
facilitatory effect and a post-synaptic effect. 
The amplitude of mEPPs may be increased by several 
processes. As mentioned earlier, the increase in frequency 
may lead to an increased probability that several quanta 
will be simultaneously released, leading to summation. 
Also, there is a possibility that the content of individual 
.. 
vesicles was 
effect. 
permeability, 
mechanisms. 
cyt o sol , may 
Rosenberg et 
altered by either a 
PLC, by altering the 
conceivably altered 
Also, PLC, by directly 
have had an effect 
al. (1968) showed that 
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indirect 
membrane 
packaging 
into the 
vesicles. 
di re ct or 
synaptic 
the 
entering 
upon the 
PLC was capable of 
entering into the cytosol of the giant squid axon. 
The increase in mEPP amplitude may also be related to 
a possible inhibition of AChE. However, the carbachol 
potential studies indicate that this mechanism cannot be a 
major factor. Another possibility leading to an increase in 
the amplitude of mEPPs lies in the unmasking of extra 
receptors in the junctional area, a hypothesis proposed by 
Harborne et al. (1978) in their studies on the action of 
PLC. 
The increase in mEPP frequency is a Ca++ dependent 
pre-synaptic phenomenon. Thus, alteration of the micro-
environment, in the area of the pre-synaptic terminal, will 
influence the spontaneous release of ACh. It has been shown 
by Hubbard et al. (1962) that hyperpolarization of the axon 
terminal has no effect upon the mEPP frequency; however, 
depolarization results in an initial increase in mEPP 
frequency (Bowman, 1980). The depolarization of the axon 
terminal could be caused by PLC in several ways: PLC might 
have a direct effect upon pre-synaptic terminals, resulting 
in an alteration in membran~ properties that lead to 
.. 
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depolarization. There may be a structural difference in the 
membrane of pre- and post-synaptic structures with the 
former being more 
depolarization may 
content increase. 
sensitive to PLC than the latter. This 
be directly related to the quantal 
Furthermore, the augmentation in the number of 
vesicles released per given time (mEPP frequency) may result 
in an increase in the ACh concentration within the synaptic 
region which, in turn, may lead to pre-synap~ic, ACh 
receptor stimulation. This hypothesis depends upon the pre-
synaptic presence of ACh receptors, and of course, on 
whether these are facilitatory or inhibitory. There are 
confusing reports on the facilitatory and inhibitory~ 
properties of pre-synaptic receptors in the NMJ preparation; 
for example, the data of Ganguly et al. ( 1979) suggest that 
there are excitatory pre-synaptic receptors that facilitate 
the release of ACh. On the other hand, Abbs et al. (1981) 
showed the presence of muscarinic inhibitory receptors. 
These conflicting results were explained by questioning the 
sensitivity of the methods used for measuring the amount of 
ACh released. Others have suggested a total absence of pre-
synaptic receptors in the phrenic nerve-diaphragm 
preparation (Gundersen et al., 1980). 
The third possibility is related to the author's 
unpublished observations. It was observed that not only was 
there an increased amplitude in individual mEPPs, but also, 
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augmented duration (half decay-time) of the mEPPs. This may 
lead to a transient increase in the extracellular K+ 
concentration, resulting in pre-synaptic K+ depolarization. 
The hypothetical depolarization mechanisms suggested 
to be involved in the PLC effect on the nerve terminal are 
directly related to the Ca++ currents, as was shown by 
Brigant and Mallart (1982). Ca++ currents ultimately are 
responsible for the increase in mEPP frequency observed as a 
results of PLC activity. Ohta and Karczmar (1981) showed 
that the pre-synaptic effects of PLC, i.e., mEPP frequency 
is blocked by Ca++ channel blockers. It is augmentation, 
possible that PLC' s pre-synaptic activity may involve the 
generation of endogenous Ca++ ionophores, such as phospha- ... 
tidic acid, which in turn may lead to an increase in the 
intracellular Ca++, resulting in the augmentation of the 
mEPP frequency (Ohta et al., 1981}. 
Quant al Content 
Quant al content measurements, based upon de l 
Castillo's and Katz' (1954) quantal hypothesis, have been 
challenged by studies done by Kriebel et al. (1974), Werning 
(1975} and others. They suggest that the classic mEPP is 
not the smallest unit of quanta released; rather the mEPP is 
composed of even smaller units which are called subunits. 
The evidence supporting the subunit hypothesis consists of 
populations of small mEPPs and the presence of multiple 
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peaks in the plots of mEPP amplitude histograms. The 
studies of Kriebel et al. (1974), Kriebel et al. (1976)' and 
Kriebel (1978), in which subunit amplitudes did not change, 
have not accounted for the post-synaptic effect. They have 
shown that colchicineJ increased Ca++ or Mg++ and increased 
temperature produce a reduction in the mEPP mode amplitude 
without changing the subunit amplitude. They interpreted 
these results as suggesting that the smallest unit is not 
the mEPP but rather the smEPP. However, studies of Mambrini 
et al. (1964) showed that increased Ca++, applied 
iontophoretically, results in a decreased ACh potential. It 
is possible that this effect was mediated by the activation 
of AChE (Hofer et al., 1984). 
Magleby et al. (1980), demonstrated that Ca++, in 
concentrations of 2-10 mM, can decrease a single channel 
current by about 30%. A similar argument can be made for 
the effect of colchicine. Anwyl et al. (1977) showed a 
decrease in post-synaptic sensitivity as a result of 
colchicine treatment. Temperature would also be expected to 
have a post-synaptic effect (Dreyer et al., 1976). 
Furthermore, Magelby et al. (1981), while investigating the 
subunit hypothesis in the frog and mouse-hemidiaphragm, 
found that they were able to record, occasionally, what 
appeared to be subunit populations. 
statistical method for evaluating 
autocorrelation, they found that 
However, by using the 
data regularity, i.e., 
the peaks were not 
.. 
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-regularly spaced as required by the subunit hypothesis. 
They concluded that, "It thus appears to us that there is 
little, if any, electrophysiological evidence that the mEPP 
is composed of subunits." They acknowledged, however, that 
there are anomalous mEPPs which could be perceived as 
subunits of mEPPs. 
There is a body of biochemical experiments suggesting 
that the vesicular hypothesis may be false, i.e., that the 
unloading of vesicular contents results in and is the only 
I 
source of mEPPs. By studying the vesicular and 
extravesitular ACh concentrations in the electric organ of 
the Torpedo, Israel and tiis collaborators (1972) found that 
due to K+ stimulation, extravesicular ACh was depleted,~ 
followed by the vesicular ACh. They also observed that 
vesicular fusion with the pre-synaptic terminal membrane is 
not always associated with ACh release. Thus, they focused 
on a different phenomenon which appeared to be consistent in 
all experiments--an increased pre-synaptic membrane particle 
density as a result of pre-synaptic electrical stimulation, 
resulting in ACh release. After isolation, they were able 
to incorporate these particles into artificial membrane 
systems. When filled with AC~ and treated with Ca++, these 
membrane systems released the ACh from within (Dunant and 
Israel, 1985). These studies may not undermine the quantal 
hypothesis, as one can easily envision a quantal-type 
rel ease generated by i ndi vi dual or synchronous rel ease of 
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ACh through the action of presynaptically embedded proteins, 
especially if their structures are comparable to ionic 
channels. 
The present work has shown an increased quantal 
content as a result of PLC application in two different 
environments: the low Ca++/high Mg++ solution used in the 
failure.method; and in a normal Ringer solution, where dTc 
half-block was used to prevent muscle contraction and the 
variance method was employed for quantal content calcula-
tion. It is apparent that PLC caused a greater increase in 
quantal content--9%--in the low Ca++/high Mg++ solution than 
in the normal Ringer. These results may not be significant 
when' interpreted in isolation (see the results for a 
discussion); however, they are supported by the EPP 
amplitude and waveform analysis data collected in the two 
different solutions (low Ca++ /high Mg++ and Ringer). This 
discrepancy may be due to PLC's sensitivity to Ca++. 
It has been shown that Clostridium welchii secretes 
two types of lipases (VandenBosch, 1978). One is specific 
f o r s p h i n go my e l i n and the o t he r f o r PLC , w h i ch h yd r o l y z es 
phosphatidylcholine, as well as, sphingomyelin (Paston et 
al., 1968). The former enzyme was shown to be independent 
of Ca++ for activation; as a matter of fact, 1 mM Ca++ 
totally inhibited its activity (Paston et al., 1968). 
.. 
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The other PLC enzyme which degraded phosphatidylcholine and 
sphingomyelin requires 5-10 mM Ca++ for optimal activity 
(Takahashi et al., 1974). 
The PLC used in this work was assayed by Sigma. Their 
assay method involves the utilization of 5 mM CaC1 2• CaC1 2 , 
of course, would inactivate the sphingomyelin-specific 
lipase and prevent its detection. Thus, there is the 
possiblity of having purchased samples contaminated by PLC 
other than phosphatidylcholine-specific PLC. 
When a Ringer-Locke solution with a normal (2 mM) Ca++ 
component was used, the PLC would be fully active and the 
data unaffected by the sphingomyelin-specific PLC. On the 
other hand, low Ca++ solution containing .235 mM of Ca++, 
would allow for the expression of the sphingomyelin-specific 
PLC. 
The ionic sensitivity of the two PLCs may be 
indicative of different mechanisms involved in the t WO 
methods for quantal content measurements. It was observed 
that in the preparation perfused with low Ca++/high Mg++ 
Ringer solution, the intracellular recordings were very 
unstable. Because of depolarization and/or muscle 
fasciculation, it was very difficult to maintain the cell's 
integrity. This observation appears to substantiate the 
membrane stabilizing properties of Ca++. Albuquerque et al. 
(1968) showed that by increasing the Ca++ concentration of 
the Ringer solution to 15 mM, they were able to reverse 
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PLC's inhibitory effect upon muscle action potential 
generation. This finding suggests the significance of this 
cation for membrane stability, as well as, its involvement 
in hydro-phylic phospholipid head groups during passive ion 
transport in the electrogenic membrane (Goldman, 1964). 
Endplate Potential (EPP) 
The form of the EPP, recorded post-synaptically with 
an intracellular electrode, depends on two processes: pre-
synaptic activation, resulting in neurotransmitter release, 
1 eadi ng to the generation of the EPP by the post-synaptic 
membrane. For a true representation of the communication 
between the pre-synaptic and post-synaptic structures, it is~ 
essential to have integrity of the post-synaptic membrane. 
Thus, the amplitude of the EPPs depends upon the amount of 
ACh released, the activity of AChE, the passive membrane 
properties of the post-synaptic membrane and the 
availability of excitable, ACh receptor-ionic channel 
complexes. The results of the present work indicate that 
PLC increases the quantal content, implying an increase in 
the number of ACh molecules released per pre-synaptic 
stimulation. Assuming that the other variables are 
constant, the increase of the number of ACh molecules in the 
synaptic cleft may lead to potentiation of the EPP by 
increasing the number of activated ionic channels. Hartzell 
et al. (1975), using a snake skeletal muscle preparation and 
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iontophoretic ACh application, showed that post-synaptic 
potentiation occurred only when there was inhibition of 
AChE. They proposed that ACh mediated post-synaptic 
potentiation occurs only when ACh quanta are not isolated 
and are allowed to diffuse laterally. These isolat~ng 
properties were attributed to AChE. PLC may alter the 
effect of AChE activity on ACh. By changing the composition 
of membrane phospholipids, the microenvironment of AChE 
molecules may be rendered less active or inactive resulting 
in an enhanced response. In the present work, PLC 1 s anti-
AChE effect is further supported by recordings in both the 
no rm a 1 R i n g er so 1 u t i on and the 1 ow Ca++/ hi g h Mg++ so 1 u t i on 
where there was a significant prolongation of the EPP 1 s 
decay-phase. To further investigate the potentiation of the 
EPP by the activity of PLC and the anti-AChE mechanism, 
possibly involved in this activity, the experimenter 
evaluated the action of PLC on bath-applied ACh, pressure-
generated ACh potentials and the carbachol responses. 
Acetylcholine Potential (ACh Potential} 
In the EPP study, the pre-synaptic structures were 
among the most important variables. In order to eliminate 
their influence, ACh was applied independently of the pre-
synaptic release. Nevertheless, because there are pre-
synaptic structures, one cannot totally eliminate their 
influence; as mentioned earlier, PLC has a significant 
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pre-synaptic effect. As in the EPP studies, the ACh 
potential studies demonstrate amplitude potentiation, 
implying that PLC has a post-synaptic effect. This 
amplitude potentiation, again, could be attributed to AChE 
inhibition. There is, however, another possibility: since 
the ACh is applied into the bath, there is no restriction on 
its diffusion. This may lead to the activation of the 
extrajunctional receptors, whose depolarization might 
influence junctional depolarization. 
agrees with the studies of Harborne et 
showed that PLC unmasked extra-junctional 
Because of the ejection electrode's 
This observation 
al. (1978), who 
spare receptors. 
position and the 
response's time-course, pressure applied ACh is more like a~ 
synaptic than a extra-synaptic response. Again, in the case 
of the bath-applied preparation, PLC potentiates the ACh 
amplitude. In regard to this effect, one must not forget 
the possible direct-receptor sensitizing phenomenon 
suggested in the early 1950s by Koppanyi and Karczmar. In 
recent years, a large body of evidence has been gathered 
t h at g i v es st r on g s u pp o rt f o r the sen s i t i .z i n g p hen omen on • 
Experiments involving sympathetic ganglion cells with 
nicotinic responses, amphibian (Akasu et al., 1981) and 
mammalian neuromuscular preparations (Ewald, 1976) showed 
potentiation with exogenous (Lamber & Parsons, 1970), as 
well as endogenous (Akasu et al., 1981) substances. 
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To eliminate the influence of AChE upon the response, 
a carbachol potential was used. Carbachol is a nicotinic 
agonist, insensitive to AChE activity (Goodman et al., 
1980). In this paradigm, PLC's effect on the carbachol 
response was very similar to that in the ACh potential. The 
carbachol potential 's amplitude was increased by 69%, 
whereas, the amplitude of the ACh response increased 82%. 
This quantitative difference between the two sets of data 
may support the hypothesis that PLC's inhibition of AChE 
contributes to its action. 
Volatage Clamp 
The voltage clamp studies evaluate the influence of 
PLC upon the ACh receptor-ionic channel complexes. There 
was a significant increase in the EPC amplitude by the 
action of PLC. Since this paradigm involves pre-synaptic 
structures, the amplitude potentiation may be attributed to 
the pre-synaptic increase in ACh release (Hartzell et al., 
1975). Anti-AChE action may also play a role in PLC 
activity (Gage et al., 1968). The carbachol potential 
studies, however, suggest that PLC's anti-AChE role may not 
be the sole contributor to EPC amplitude enhancement. It is 
not unreasonable to speculate that PLC may have an effect 
upon the post-synaptic membrane, influencing the function of 
ACh receptor-ionic channel complexes. This effect was 
observed in the analysis of EPP waveforms where the 
.. 
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decay-phase was prolonged. The analysis of the EPC 
waveforms revealed that the decay-phase was also 
significantly prolonged. Gage et al. (1974) found an effect 
very similar to those presented in the present work. In 
their studies of aliphatic alcohols on the conductance 
change caused by ACh, they found that ACh increased the 
current amplitude without changing the exponential decay; 
however, the decay-time was prolonged. The voltage 
sensitivity of these channels was unchanged. Gage proposed 
that alcohol molecules become incorporated into and alter 
the function of the channel's microenvironment slowing the 
gating processes of individual channels. The mechanism 
proposed as an explanation for this phenomenon was an~ 
increase in the membrane's dielectric constant. 
The concept of an altered membrane dielectric constant 
is clouded by the complex physics of dielectrics; thus, the 
mathematic model will not be discussed in detail. Simply, 
the dielectric constant is the ratio between measured 
capacitance in a capacitor with a given material between its 
plates, and the capacitance of a perfect capacitor with a 
vacuum between its plates. Every material has a dielectric 
constant; they range from 6 for porcelain to 2.9 for beeswax 
to 1.0 for stream water (The Handbook of Chemistry and 
Physics, 65th Edition, 1984-1985, p. E-31-55, CRC Press). 
Direct studies have shown that the dielectric constant may 
play a role in the functional properties of membranes. 
209 
After the dielectric constant of the membrane increases 
through the incorporation of chlorinated hydrocarbon {1-
chlorodecane), there was an enhanced membrane permeability 
(Dilger et al., 1979). If PLC action upon the junctional 
membranes alters the membrane dielectric constant, then, one 
would expect to observe changes in membrane permeability 
and/or capacitance. 
The present studies do not show a significant change 
in the membrane resistance. The time constant also appears 
unchanged, implying no observable change in the capacitance. 
Under these circumstances, an explanation is difficult to 
find. If one assumes that the dielectric constant is indeed 
altered, then the capacitance must be involved. This~ 
involvement, however, may be small enough to be undetected, 
but large enough to influence the decay-rate (Gage et al., 
1975). 
Another possibility involves the vertical displacement 
hypothesis of Borochov and Shinitzky (1976) (see the intro-
duction for details). A phospholipase, like PLA2, was found 
to decrease membrane fluidity (Liu et al., 1983). 
Phospholipase C may act in a similar way. An increase in 
membrane rigidity may lead to vertical displacement of the 
newly formed receptors. This process may enhance the new 
receptor's arrival at the surface, resulting in a larger 
density of receptors. This has been shown 
studies of cholinergic receptors following 
treatment of the membranes (Hershkowitz, 1982). 
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by binding 
ch o 1 es t·e r o l 
The altered morphology and physiology of post-synaptic 
membrane's may result from rigidification. The post-
junctional membrane is a heterogeneous structure in both 
receptor distribution and morphology. The top of the post-
junctional membrane has a high density of filamentous 
structures (Brisk, 1966) and is packed with receptors. The 
receptors at the bottom of the folds, however, are much less 
dense (10% of the top) and are indistinguishable from the 
extrajunctional receptors (Sal peter et al., 1983). These 
two receptor types differ. It appears that the unit 
conductance of the junctional receptor-ionic channel 
complexes (RICC) is 20-30 pS while extracellular RICCs 
exhibit a unit conductance of 10 pS; also the opening time 
for junctional RICCs is 2-3 times shorter than the 
extrajunctional RICCs (Dreyer et al., 1976; Dreyer et al., 
1976). Thus, after modifying the post-synaptic achitecture 
by PLC application, one may observe a less defined 
structural organization, allowing ACh to reach a 
heterogeneous population of junctional and extrajunctional 
receptors. 
.. 
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Electrotonic Potential 
A hyperpolarizing pulse was usP.d to check the effects 
of PLC, in concentrations of 0.1 u/ml, upon the neuro-
muscular preparation used over the duration of drug 
application. When the preparation survived the duration of 
the experiment, there was no significant changP. in the 
resistance or the waveform. An unusually high number of 
preparations were not able to be maintained throughout the 
experiment (70%). Though the current/voltage relationship 
was not obtained, it is possible that the hyperpolarizing 
current had an effect upon the activity of PLC. 
.. 
CONCLUSION 
This study has shown that PLC from Clostridium welchii 
has a complex effect upon the neuromyal junction of a mouse, 
phrenic nerve-diaphragm 
concentrations of .1 u/ml 
C, this enzyme did not 
preparation. Generally, in 
applied for 15-30 minutes at 30° 
show a post-synaptic depolarizing 
effect: higher concentrations caused a depolarizing effect 
which appeared to be dependent upon the duration of 
application. The depolarizing effect was not reversible 
with the wash. Heat deactivated PLC, in a concentration of 
25 u/ml, had no depolarizing effect. 
Pre-synaptically, PLC, .1 u/ml, caused a 64~ increase 
in the frequency of mEPPs. This mechanism may be Ca++ 
dependent (Ohta and Karczmar, 1981). The quantal content 
increased in both the normal Ringer and low Ca++/high Mg++ 
Ringer, 23% and 32%, respectively. This difference may be 
due to PLC's sensitivity to Ca++. There was no observed 
effect of PLC at .1 u/ml upon the compound axonal potential. 
Post-synaptically, both the ACh potential and the 
carbachol potentials were enhanced by PLC. These results 
are in agreement with those of Watson et al. (1976) and 
Harborne et al. (1978), who proposed that PLC may unmask the 
spare receptors. Other augmenting mechanisms may involve a 
direct sensitization of receptor-ionic channel complexes or 
anti-cholinesterase activity. The electrotonic potential 
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experiments showed no PLC effect at .1 u/ml on the waveform; 
h owe v e r , bot h the E PP and E PC de c a y -t i mes we re i n c re a ·s e d • 
This increase in the EPP and EPC decay-times suggests the 
involvement of PLC in the alteration of channel kinetics. 
Since decay-time is an indicator of the average channel 
lifetime, prolongation of this phase implies an enhanced 
average time during which a channel is open. The mechanism 
involved may be related to the specific bi ochemi ca 1 action 
of PLC. Since most of the phosphotidylcholine molecules are 
located in the outside layer of the membrane and 
phosphotidylcholine is an important component of the 
membrane, PLC activity might result in perturbation of this 
system. This perturbation might lead to the modification of~ 
membrane fluidity which in turn might be correlated to the 
observed channel effects. 
Considering the fact that PLC had influence upon both 
pre- and post-synaptic events, it is not surprising to see 
PLC's influence upon the "mixed effects". The mEPP 
amplitude was enhanced by 12%, the EPP amplitude was 
enhanced by 24% and the EPC was increased by 12%. 
This study points to the importance of membrane 
phospholipids in signal processing. Although phospholipid 
membranes may not play a direct role in carrying ionic 
species during signal generation, phosphotidylcholine, in 
particular, appears to play an integral role in the 
maintenance of the protein's functional integrity. 
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APPENDIX I 
APPENDIX I 
Components of the recording system: 
A & B: amplified analogue inputs 
236 
A-D: A to D converter by Tecmar (Labtender) 
BA: bath application of Ach 
c: trigger pulse. 
CE: common electrode 
DA: data acquisition program 
DB: zenner diode box 
ON: data analysis program 
DP: data plotting program 
OS: data storage program 
ET: electronic thermometer VSI (73A) 
FM: FM tape recorder VETTER (Mod. D) 
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GB: gas bubbler 
HP: heating perfusion HAAKE {FSe) 
IE: current recording electrode 
IBM: IMB XT PC 
IS: internal suction for CAP electrode 
IU: isolation unit Grass {SILIS) 
KB: keyboard {IBM) 
M: monitor {IBM) 
N2: nitrogen gas tank 
o1: oscilloscope & amplifier Tektronix {5103N) 
02: oscilloscope Tektronix {3A3) 
PE: pressure ejection electrode 
PIU: pressure isolation unit 
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PR: digital printer IBM 
PRS: perfusion regulating system 
s1 & S2: stimulators Grass (S-88) 
SE: stimulating electrode in oil chamber 
SER: suction recording electrode 
VR: voltage recording electrode 
WPI: preamplifier unit WPI with S-7050A, S7071A, 
S7100A 
APPENDIX II 
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APPENDIX II 
Programs written in BASICA: 
TIMEGRPH: plots collected data, i.e., EPPs amplitudes 
versus the time duration of the experiment. 
TIMERMP: plots the RMP amplitude versus the time 
duration of the experiment. 
BAKUPDATA.1: back-ups data {both EPP & RMP) from the 
hard disc to the soft disc. 
EPX: collects on-line EPP and RMP data. 
AMPEVOK: calculates the quantal content from the 
failure and variance method experiments. 
WAVERAGE.2: averages individual waveforms and 
calculates the 50% rise-time and the 50 & 75% decay-
times. 
.. 
241 
Programs written in "Cff: 
AVGFRQPLT: This program plots the mEPP frequency versus 
time. 
AVGAMPPLT: plots the mEPP amplitude versus time. 
AVGRMPPLT: plots the RMP versus time. 
CLGSP: clears the plots saved on the disc. 
PRGSP: prints all of the graphic screens saved on the 
disc. 
DEX PD: 
discs. 
transfers the data from the hard to the soft 
GETMEPP: collects the mEPP data. 
Programs written in APL: 
WORK2: is a general di rectory for storing "working" 
data, i.e., collecting programs. They do not have 
names, but rather are addressed by pressing the F keys 
from the keyboard. They are: 
.. 
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F1: Retrieve a specified waveform from the hard disc. 
F2: Clean the graphics from the screen. 
F3: Switch the operation to the text for a choice of 
the next function. 
F4 : Switch the computer operation to the graphics 
mode. 
F5: Switch the computer to the data collecting mode. 
F6: Save a specific waveform on the hard disc. 
F7: Plot the data on the monitor screen. 
F8: Plot the axis of the graph on the monitor screen. 
Fg: Plot the data via the dot matrix printer. 
F10 : Set the parameters for data acquisition, i.e., 
sensitivity, time gain, etc. 
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More programs written in APL. These programs are addressed 
by pressing Ctr and an F key: 
F1: erases the saved waveforms. 
F2: allows for a change in the plot title. 
F3: averages the waveforms as designated by the 
experimenter. 
F4 : resets the averager to O. 
F5: reads the maximums of the saved waveforms. 
F6 : plots waveform amplitudes over-time. 
F7: plots the averaged data. 
F8 : backs-up onto a soft disc and retrieves data 
points from that disc. 
F9: automatically saves waveforms onto the hard disc. 
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TTEST: is a directory which contains programs designed for 
statistical analysis. These programs are addressed by 
pressing F keys and Ctr from the keyboard. 
F1: analyzes two groups of data from the hard disc as 
defined by the experimenter. 
F2: calculates t-test values, i.e., SD, SE, t, p, etc. 
for the data entered from the keyboard. 
F3: estimates the sample size needed to achieve the 
desired significance, when given the variance. 
F4: allows for the entry of data from the keyboard. 
Some commands needed for editing data and changing from the 
acquisition mode to the calculation mode: 
Ctr & T: al 1 ows one to set-up tabs for the data 
intended for elimination. 
Ctr & D: eliminates the specified data. 
Ctr & E: shifts the mode of operation from data 
acquisition to calculation. 
.. 
APP ENO IX I I I 
.. 
246 
Appendix III 
This appendix contains the names of the enzymes, used in the 
text of this dissertation, and the number assigned to them 
by the INS Enzyme Commission. 
Acetylcholinesterase: (AChE) (E.C. 3.1.1.7) 
Phospholipase Ai: (PLAl) ( E • C • 3.1.1.32) 
Phospholipase A2: (PLA2) ( E. c. 3.1.1.4) 
Phospholipase c: (PLC) ( E • C • 3.1.1.5) 
Phospholipase D: (PLO) (E.C. 3.1.4.39) 
... 
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.. 
Appendix IV 
Drugs and enzymes used in the present work: 
Acetylcholine chloride (ACh) 
Carbamylcholine (Carb) 
Phospholipase C (PLC) type XII 
Tetrodotoxin (TTX) 
d-Tubocurarine chloride (dTc) 
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All of the drugs were purchased from the Sigma company. 
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